Technology-Enabled Community Health Workers: Bridging Treatment Gaps in Underserved Polish Communities

Executive Summary

This policy paper presents a comprehensive framework for implementing technology-enabled Community Health Workers (CHWs) to address critical gaps in addiction treatment across underserved Polish communities. Poland faces significant challenges in substance use disorder (SUD) treatment, including regional disparities, workforce limitations, and persistent stigma. The proposed solution leverages CHWs as trusted community members who can bridge the divide between vulnerable populations and formal healthcare systems.

The international evidence demonstrates that properly trained and supported CHWs can significantly improve addiction treatment outcomes by enhancing outreach, facilitating treatment engagement, providing recovery support, and delivering harm reduction services. When empowered by appropriate technology, CHWs can extend their reach and effectiveness, particularly in rural and underserved areas where specialist services are limited.

Key recommendations include:

1. Establish a formal CHW role within Poland's healthcare system through appropriate regulatory frameworks, standardized training curricula, and clear scope-of-practice guidelines that complement existing professional roles.
2. Implement a phased approach beginning with pilot programs in strategically selected voivodeships (Podkarpackie, Łódzkie, and Zachodniopomorskie) that represent diverse geographic, socioeconomic, and substance use challenges.
3. Integrate digital health technologies including mobile applications for recovery support, telehealth platforms for specialist consultation, and offline-capable tools designed to function in areas with limited connectivity.
4. Develop sustainable financing mechanisms through the National Health Fund (NFZ), dedicated allocations from national addiction programs, and potential EU funding streams to ensure long-term viability.
5. Address implementation barriers proactively by engaging medical associations early, developing anti-stigma campaigns, ensuring technology accessibility, and creating robust data privacy protections.
6. Conduct rigorous evaluation measuring treatment initiation and retention, client outcomes, cost-effectiveness, healthcare integration, and CHW job satisfaction to inform program refinement and national scaling.

The proposed model acknowledges Poland's specific cultural context, healthcare structure, and regional diversity while drawing on international best practices. By thoughtfully integrating CHWs supported by appropriate technology, Poland can significantly improve addiction treatment accessibility and outcomes, particularly for vulnerable populations in underserved areas. This approach represents a cost-effective strategy to reduce the substantial personal, social, and economic burden of substance use disorders while building stronger, healthier communities.

Current Landscape of Addiction Treatment in Poland

Poland faces substantial and multifaceted challenges in addressing substance use disorders (SUDs). The nation grapples with a significant burden of alcohol use disorder (AUD), with estimates from previous national health surveys indicating a substantial public health problem (e.g., [Placeholder: Specific PARPA or GUS Health Report, c. 2020-2022]). This aligns with broader European trends where alcohol remains a major public health concern (Rehm et al., 2019). Alongside AUD, Poland is witnessing a concerning rise in illicit drug use, particularly pronounced in rural and economically disadvantaged regions (European Monitoring Centre for Drugs and Drug Addiction [EMCDDA], 2023a). This pattern of increased substance use in vulnerable populations mirrors trends in other countries where socioeconomic deprivation correlates with higher rates of SUDs (Das-Munshi et al., 2020).

The primary legal framework governing addiction in Poland consists of the Act on Counteracting Drug Addiction and the Act on Upbringing in Sobriety and Counteracting Alcoholism. Key institutions such as the National Bureau for Drug Prevention (Krajowe Biuro ds. Przeciwdziałania Narkomanii - KBPN) and the State Agency for Prevention of Alcohol-Related Problems (Państwowa Agencja Rozwiązywania Problemów Alkoholowych - PARPA) play central roles in policy development and prevention efforts (KBPN, n.d.; PARPA, n.d.).

The National Bureau for Drug Prevention has previously highlighted a critical treatment gap, with past reports indicating that a significant percentage of individuals requiring addiction treatment did not receive appropriate care (e.g., [Placeholder: Specific KBPN Report on Treatment Accessibility, c. 2019-2021, with specific percentage]). This substantial gap underscores a systemic challenge in connecting those in need with available services. Such treatment gaps represent a global phenomenon; for instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the United States has consistently reported large unmet treatment needs (SAMHSA, 2023). An older analysis also pointed to long-standing issues in treatment accessibility across various substances (Open Society Foundations, 2010), though more current data is needed to reflect the contemporary situation accurately.

These gaps in treatment access can lead to severe consequences, including the development of unregulated markets for medications, as individuals unable to access legitimate treatment seek relief elsewhere (NPR, 2018). A study examining the SUD treatment gap for low-income adults following the Affordable Care Act (ACA) in the U.S. also highlighted persistent barriers despite policy changes (Saloner et al., 2023). In Poland, addiction treatment services are primarily financed through the National Health Fund (Narodowy Fundusz Zdrowia - NFZ), which contracts services from public and non-public providers, including outpatient clinics, day centers, and inpatient facilities, some of which are run by well-established NGOs employing models like therapeutic communities (GUS, 2022; [Placeholder: NFZ Report on Addiction Service Contracting, Year]).

The structure of Poland's healthcare system, which involves centralized planning and regional NFZ branches, has historically led to a concentration of resources and specialized services in urban centers. This centralization leaves rural and remote communities with markedly limited access to specialized addiction treatment facilities and professionals (Kowalczyk et al., 2021). This urban-rural disparity is a common theme internationally. For example, rural areas in the United States often face a scarcity of healthcare providers, including addiction specialists, leading to "treatment deserts" (Rural Health Information Hub, 2023). In contrast, countries like Australia have implemented specific national rural health strategies to mitigate these disparities, including financial incentives and telehealth expansion, though challenges remain (Australian Government Department of Health and Aged Care, 2023).

The consequences of this centralized approach in Poland are evident in treatment accessibility metrics. According to data that would typically be reported by the Polish National Health Fund, average waiting times for addiction treatment in some rural areas can be significantly longer than in major urban centers (e.g., [Placeholder: Specific NFZ Report on Waiting Times, c. 2022-2023, detailing rural vs. urban figures]). Such prolonged waiting times can have devastating impacts, leading to a worsening of the individual's condition, increased risk of co-occurring health problems, disengagement from the treatment-seeking process, and higher societal costs (Probst et al., 2017). The Polish National Health Program (Narodowy Program Zdrowia) for recent years outlines objectives to improve mental health and reduce substance-related harm, but translating these goals into equitable access across all regions remains a significant policy challenge ([Placeholder: Narodowy Program Zdrowia, Relevant Edition, e.g., 2021-2025]).

This disparity in access and waiting times is further exacerbated by several interconnected factors. Pervasive stigma surrounding addiction remains a significant barrier to help-seeking in Poland, deeply rooted in cultural attitudes and often more pronounced in smaller, close-knit rural communities where anonymity is harder to maintain (L Knaak et al., 2017; [Placeholder: Polish Sociological Study on Addiction Stigma, Year]). Individuals may fear social exclusion, discrimination, or judgment, preventing them from acknowledging their SUD or seeking professional help. Policy interventions must therefore address not only service provision but also the social and cultural barriers that prevent treatment engagement.

While the NFZ funds addiction treatment, there are ongoing debates about the adequacy and equitable distribution of funding for community-based addiction services, particularly in underserved regions, compared to hospital-centric care (Kowalczyk et al., 2021). This mirrors a broader issue seen in many healthcare systems where funding for mental health and addiction services may not always align with population needs or achieve parity with physical health investments (Milliman, 2022). Policymakers must consider whether current funding mechanisms adequately incentivize service provision in areas of greatest need, and whether alternative payment models might better support comprehensive community-based care.

A critical shortage of healthcare professionals specializing in addiction medicine, particularly those willing to work in underserved rural regions, further compounds access problems. Polish government initiatives to address healthcare workforce shortages in underserved areas have been implemented, but their specific impact on addiction specialists in rural settings requires further evaluation ([Placeholder: Ministry of Health Report on Workforce Incentives, Year]). Effective policy must address both the supply of qualified professionals and their distribution across regions of need.

Regional Disparities in Treatment Access

The geographical distribution of addiction treatment services in Poland reveals stark regional inequalities. Reports from Polish health authorities or research institutions would typically indicate that certain voivodeships (provinces), often those in eastern and southeastern Poland, exhibit significant deficits in service availability (e.g., [Placeholder: KBPN or PARPA Regional Analysis Report, c. 2021-2022]). In these regions, the ratio of addiction specialists to residents might be considerably lower than in major metropolitan areas like Warsaw (e.g., [Placeholder: NIL or Ministry of Health Data on Specialist Distribution, Year, with specific ratios]). While specific international benchmarks for specialist-to-population ratios vary, such wide internal disparities clearly indicate inequitable access (World Health Organization [WHO], 2018).

These Polish regions often grapple with lower socioeconomic indicators, higher unemployment, and depopulation, which can both contribute to higher rates of SUDs and make these areas less attractive for healthcare professionals (GUS, 2023). This creates a troubling paradox where areas with potentially greater need often have fewer resources, highlighting the importance of policy approaches that specifically target resources to areas of greatest vulnerability.

Transportation barriers significantly compound these access issues for rural inhabitants. Average travel time to reach an addiction treatment facility can be substantial in many rural Polish communities, as suggested by analyses of healthcare accessibility (e.g., [Placeholder: Polish Study on Rural Healthcare Access, Year, with travel time data]). This is a well-documented barrier in rural healthcare globally. Studies in the U.S. and Canada have shown that long travel distances reduce treatment initiation, engagement, and completion rates (Fortney et al., 2007; Pullen & Oser, 2014). The lack of reliable public transportation in many rural Polish areas further isolates individuals who may not have access to private vehicles or the financial means for frequent travel.

This can be especially challenging for individuals with co-occurring physical disabilities or mental health conditions. Digital literacy and access to stable internet, crucial for telehealth alternatives, also vary across Poland, potentially creating new disparities if technology-based solutions are not implemented equitably ([Placeholder: Polish Digital Literacy Report, Year]). Policy solutions must therefore consider transportation infrastructure, digital connectivity, and the potential for mobile services as integral components of addiction treatment accessibility.

While Poland's population is more homogenous than some countries where racial and ethnic disparities in medication for opioid use disorder (MOUD) use are documented (Joudrey et al., 2020), analogous disparities in Poland likely exist based on socioeconomic status, urban versus rural residence, and potentially among minority ethnic or linguistic groups. Specific Polish research comprehensively detailing such disparities in addiction treatment access represents an area for further investigation. The principles of inequity, however, remain relevant: marginalized groups often face greater hurdles in accessing evidence-based care, and policy approaches must be sensitive to these potential disparities.

Workforce Limitations

Poland is contending with a critical shortage of addiction specialists (terapeuci uzależnień) and medical doctors specializing in addiction medicine (lekarze psychiatrzy specjalizujący się w leczeniu uzależnień). Data from the Polish Medical Chamber (Naczelna Izba Lekarska - NIL) or the Ministry of Health would be needed to quantify the exact percentage of physicians specializing in addiction medicine, but reports often indicate it is a small fraction of the total physician workforce (e.g., [Placeholder: NIL Report on Medical Specializations, c. 2022-2023, with percentage]). This low proportion highlights a systemic challenge in developing and retaining this specialized field.

For context, while direct comparisons are difficult due to varying healthcare system structures and definitions of "specialist," many Western European countries have also reported shortages but have often invested more heavily in training and integrating addiction medicine (Council of Europe, Pompidou Group, 2021). The consequences of such a shortage include overburdened existing specialists, long waiting lists, and a potential reliance on less specialized or non-evidence-based treatment approaches. Policy interventions must therefore address both the pipeline of new specialists and the retention of existing professionals.

This scarcity of addiction specialists is particularly acute in rural and underserved regions. Recruitment and retention of healthcare professionals in these areas are persistent challenges, driven by several factors. Compensation and incentives for healthcare professionals, including addiction specialists, may be less competitive in rural areas compared to urban centers, despite potential government programs aimed at mitigating this (OECD, 2023; [Placeholder: Polish Ministry of Health data on rural physician compensation, Year]). Rural practitioners may have fewer opportunities for continuous medical education, peer collaboration, research involvement, and career advancement (Kinnman et al., 2020). Working in remote areas can lead to professional isolation, with fewer colleagues for support and consultation (Rural Health Information Hub, 2023). Additionally, rural facilities often operate with tighter budgets and fewer resources, which can impact the quality and scope of services they can provide (Pullen & Oser, 2014).

These challenges are not unique to Poland. Many countries have implemented various strategies to attract and retain healthcare workers in rural areas, such as loan forgiveness programs, increased training slots for rural practice, and enhanced telehealth support (Government of Canada, 2023; Australian Government Department of Health and Aged Care, 2023; Health Resources & Services Administration [HRSA], 2023). Polish policymakers would benefit from evaluating these international approaches and adapting promising practices to the Polish context.

The existing workforce limitations in Poland necessitate innovative solutions. While Poland has certified addiction therapists and therapy instructors, the specific role of a Community Health Worker (CHW) as understood in some other countries (e.g., MHP Salud, 2021; Florida Certification Board, 2022) or Peer Support Specialists (e.g., Oregon Health Authority, 2023; SAMHSA, 2017) is less formally established or widespread within the Polish addiction care system. Integrating such roles, particularly when empowered by technology, presents a promising avenue for extending the reach of addiction services.

However, successful implementation would require careful policy consideration of training requirements, supervision structures, integration with existing professional teams, defining scope of practice, and addressing potential resistance from established professional groups or skepticism regarding non-traditional roles within the Polish healthcare context. Alternative solutions, such as expanding telehealth capabilities for existing specialists, further integrating addiction care into primary healthcare settings, and enhancing prevention efforts, must also be part of a comprehensive policy strategy. The deployment of technology-enabled CHWs represents one component of a multi-pronged approach to address Poland's addiction treatment gaps, requiring thoughtful policy development to ensure effectiveness, quality, and sustainability.

Community Health Worker Models: International Evidence and Critical Perspectives

Community Health Workers (CHWs) represent a powerful yet underutilized resource in addressing the global addiction crisis. As defined by the World Health Organization, these individuals serve as vital bridges between health services and communities, possessing either membership in or an unusually close understanding of the populations they serve (World Health Organization, 2018). The compelling need for innovative approaches to addiction treatment cannot be overstated—approximately 296 million people worldwide use drugs, with 39.5 million suffering from drug use disorders (UNODC, 2023). This chapter examines the international evidence supporting CHW integration into addiction treatment frameworks, while maintaining a critical perspective on implementation challenges and limitations.

Successful CHW Models in Addiction Treatment: Diverse Approaches and Outcomes

The global landscape of CHW implementation in addiction services reveals adaptable models with promising outcomes, though the quality and specificity of evidence varies considerably across contexts.

The Extension for Community Healthcare Outcomes (ECHO) model exemplifies how technology can amplify CHW effectiveness in addiction treatment. This telementoring approach connects specialist teams with primary care providers and CHWs through regular virtual clinics, employing case-based learning to build local treatment capacity (Arora et al., 2011). CHWs participating in Opioid Addiction Treatment teleECHO programs report increased confidence and capacity in supporting patients with substance use disorders (CHW Central, 2019). The model has proven particularly valuable in expanding Medication for Addiction Treatment (MAT) access in underserved areas (National Institute on Drug Abuse [NIDA], 2023). While some reports suggest significant improvements in treatment retention and reduced emergency department utilization, caution is warranted regarding specific outcome claims pending more robust CHW-specific research (Zhou et al., 2022). The COVID-19 pandemic accelerated ECHO's adoption, highlighting its utility in providing remote training and support for CHWs managing addiction cases (SAMHSA, 2021).

Scotland's Recovery Community model offers a contrasting approach centered on peer support workers—CHWs with lived experience of addiction. This model fundamentally recognizes that individuals successful in their own recovery possess unique capabilities to support others (Scottish Government, 2021). Their shared experiences foster trust and diminish stigma in ways professional credentials alone cannot achieve (SAMHSA, 2022). While specific comparative outcome claims require careful scrutiny, broader research supports the value of peer support in increasing treatment engagement, reducing relapse, and improving social functioning (Bassuk et al., 2016; Reif et al., 2014). The formalization of Peer Support Specialist roles in various jurisdictions, including Oregon, underscores the growing recognition of lived experience as a valuable qualification in addiction services (Oregon Health Authority, 2023).

Lithuania's community-based addiction counselor model demonstrates how CHW-like roles can bridge primary care and specialized addiction services, particularly in resource-constrained rural settings. While specific outcome claims regarding treatment engagement improvements require additional substantiation, the strategic deployment of community-based personnel alongside telehealth technologies represents a pragmatic approach to enhancing service access (Gytis et al., 2019). The integration of basic digital tools for telemedicine and record-keeping further illustrates how technology can extend CHW reach and effectiveness (Telehealth.HHS.gov, 2023).

In low- and middle-income countries (LMICs), emerging CHW models for addiction often operate with less formal documentation but show promising adaptations to local contexts. South African CHWs have successfully delivered screening and brief interventions for alcohol use disorders in primary care settings (Sorsdahl et al., 2021), while Vietnamese community health workers support MAT programs for opioid use disorder (Nguyen et al., 2019). These models require significant adaptation to local resources, cultural norms, and substance use patterns, facing challenges including limited funding, lack of standardized training, and difficulties integrating with fragmented health systems (Kemp et al., 2019).

Cultural adaptation represents a critical dimension of effective CHW interventions for addiction. For Indigenous communities, models incorporating traditional healing practices and addressing historical trauma demonstrate greater effectiveness (Dell et al., 2011; Substance Abuse and Mental Health Services Administration [SAMHSA], 2019). Similarly, immigrant and refugee populations benefit from CHWs who share language and cultural backgrounds, helping overcome barriers including stigma and system mistrust (Napoles et al., 2018). Tailored communication approaches, understanding of family dynamics, and addressing specific social determinants of health prove essential for CHW effectiveness across diverse cultural contexts (Ingram et al., 2020).

Cost-Effectiveness: The Economic Case for CHW Integration

The economic argument for integrating CHWs into addiction treatment systems remains compelling yet requires stronger evidence specific to addiction interventions. While general studies on CHW interventions for chronic diseases suggest favorable cost-benefit ratios (Nkonki et al., 2017), more rigorous analyses focused specifically on addiction are needed to fully substantiate claims of cost-effectiveness.

The theoretical economic benefits of CHW involvement in addiction care operate through multiple pathways. By providing proactive support and improving treatment adherence, CHWs can prevent costly emergency department visits and hospitalizations (NIDA, 2023). Their support of successful recovery contributes to improved workforce participation and economic contribution (NIDA, 2023). CHWs effectively guide individuals to appropriate outpatient services, often more cost-effective than acute care (Cartwright, 2000), while addressing social determinants of health to reduce long-term disease burden (WHO, 2021).

Policy makers should recognize that while initial investment in CHW programs may appear substantial, the potential return on investment through reduced healthcare utilization, decreased criminal justice involvement, and improved productivity warrants serious consideration. Future research must prioritize controlled designs with clearly defined outcomes to strengthen the economic case for CHW integration in addiction services (Ritter & Cameron, 2006).

Evidence-Based Approaches and Harm Reduction Facilitated by CHWs

CHWs excel not as clinical specialists but as facilitators who enhance access to and engagement with evidence-based addiction treatments. They educate about Medication for Addiction Treatment, combat stigma, assist with logistics, and support medication adherence (National Academy for State Health Policy [NASHP], 2022; NIDA, 2023). CHWs address practical barriers to behavioral therapy participation, support contingency management protocols in community settings (Petry et al., 2018), and with appropriate training, facilitate engagement in promising mindfulness-based interventions (Priddy et al., 2018). Those functioning as peer support workers provide direct evidence-based psychosocial support (SAMHSA, 2022; Bassuk et al., 2016).

In harm reduction, CHWs play an increasingly crucial role that warrants greater policy support. They effectively distribute naloxone and train communities in its use to prevent overdose deaths (Beletsky et al., 2018). CHWs serve as vital connections to syringe services programs, reducing infectious disease transmission (Islam et al., 2018), and can facilitate access to safer consumption sites where they exist, connecting highly marginalized individuals with health and social services (Kolla & Strike, 2020). Their ability to build trust with people who use drugs makes them uniquely effective in delivering harm reduction messages and supplies.

Policy frameworks should explicitly recognize and support these harm reduction functions, removing legal and regulatory barriers that may impede CHWs from delivering these evidence-based interventions. Addiction policies that embrace harm reduction alongside treatment and prevention create more comprehensive systems where CHWs can maximize their impact across the continuum of care.

Current Challenges in Addiction Policy and CHW Implementation

Despite their potential, significant policy and implementation challenges must be addressed to optimize CHW effectiveness in addiction services. Sustainable funding remains perhaps the most critical barrier. While some jurisdictions explore Medicaid reimbursement or alternative payment models, consistent financing mechanisms are far from universal (NASHP, 2022; Centers for Disease Control and Prevention [CDC], 2022). Policy innovations that create dedicated, stable funding streams for CHW services in addiction treatment would significantly enhance sustainability.

The lack of standardized training, certification, and clearly defined scopes of practice creates inconsistency and potential quality concerns (Rosenthal et al., 2010). Policy frameworks should establish core competencies for addiction-focused CHWs while maintaining sufficient flexibility to accommodate diverse community needs and cultural contexts. Effective integration into existing health systems requires clear role definition, interprofessional respect, and robust communication pathways within multidisciplinary teams (Kangovi et al., 2020).

Workforce wellbeing represents another critical policy consideration. CHWs need adequate clinical supervision, mentorship, and support to manage complex cases and prevent burnout, vicarious trauma, and turnover (O'Donovan et al., 2021; CDC, 2022). Policies must actively address stigma—both that faced by people with addiction and that potentially experienced by CHWs themselves (Livingston et al., 2012).

Equity considerations demand particular attention. While CHWs excel at reaching underserved populations, specific strategies are needed for highly marginalized groups. There exists a risk that CHW deployment could inadvertently reinforce existing disparities if implemented without a strong equity lens, for example, by concentrating less-resourced workers in already underserved areas without adequate systemic support (Olaniran et al., 2021).

Additional challenges include inadequate data collection systems that limit evaluation of CHW activities and outcomes (Scott et al., 2018), the need for adaptable approaches to address polysubstance use and emerging drug threats (Cicero et al., 2020), and professional resistance and regulatory hurdles related to scope of practice and reimbursement (Advisory Board, 2019).

Limitations and Critical Perspectives on CHW Models

A balanced policy approach requires acknowledging that CHW models, while promising, are not without limitations. Implementation failures can result from inadequate funding, poor training and supervision, lack of community buy-in, or unrealistic expectations placed upon CHWs (Glenton et al., 2013). Potential unintended consequences include overburdening CHWs with excessive caseloads or tasks beyond their training, leading to stress and reduced effectiveness (O'Donovan et al., 2021).

More subtle concerns include the risk of co-optation, where CHWs become viewed merely as inexpensive extensions of formal health systems rather than true community advocates (Nkonki et al., 2017). Professional boundary issues can arise, particularly for peer CHWs navigating dual roles within their communities (Shipton et al., 2021).

Alternative approaches to addressing addiction treatment gaps—including expanding specialist services, integrating addiction treatment into primary care, technology-driven interventions, and broader public health campaigns—should be considered alongside CHW models (Humphreys & Lembke, 2014). Critics rightfully caution that overreliance on CHWs without addressing systemic issues like underfunding of specialist services or social inequities may represent a stop-gap measure rather than a fundamental solution (Frieden, 2015).

Technology Integration for Enhanced CHW Effectiveness in Addiction Treatment

The Digital Frontier in Community-Based Addiction Care

Digital health technologies present a transformative opportunity to amplify the impact of Community Health Workers (CHWs) in addressing critical addiction treatment gaps, particularly in Poland's diverse healthcare landscape. The global addiction treatment community increasingly recognizes technology's value in extending care reach, improving outcomes, and serving marginalized populations (World Health Organization, 2020). Evidence from multiple European and international contexts demonstrates that thoughtfully integrated technology can significantly enhance community-based interventions while maintaining the human-centered approach that defines quality care (Marsch et al., 2014).

CHWs, valued for their trusted community status and ability to provide nonjudgmental support, occupy a unique position to leverage these technologies effectively (MHP Salud, 2021; Florida Certification Board, n.d.). This potential is particularly relevant in Poland, where an estimated 100,000 people engage in high-risk drug use, primarily involving opioids or stimulants, and where specialized treatment access remains limited, especially in rural communities (EMCDDA, 2023a). In this context, enhancing CHW effectiveness through strategic technology integration represents not merely a technical upgrade but a critical policy imperative for addressing addiction challenges nationwide.

Mobile Health Applications: Extending the Reach of Recovery Support

Mobile health applications designed specifically for addiction recovery support have demonstrated considerable promise across various settings, though their effectiveness varies based on specific applications, populations served, and substances addressed (AlMarwani et al., 2023). These digital tools can fundamentally transform addiction care delivery by making support more accessible, continuous, and personalized to individual needs.

Finland's A-Clinic Foundation offers an instructive example through their Previct digital platform, which connects CHWs with clients via smartphone applications. This system has reportedly improved treatment adherence, though independent verification and context-specific validation remain essential before considering widespread adoption in Poland (A-Clinic Foundation, n.d.). The growing utility of such platforms finds support in comprehensive research; literature reviews consistently show that digital health interventions, including mobile applications, can significantly improve outcomes for individuals with Substance Use Disorders (SUDs) by enhancing self-management capabilities, treatment engagement, and support access (AlMarwani et al., 2023). However, policy makers must recognize that not all applications deliver equal benefits, and many commercially available options lack rigorous evidence supporting their efficacy (Larsen et al., 2019).

Effective recovery support applications typically feature daily check-ins and mood tracking that allow real-time monitoring of client states and potential relapse triggers, though this data requires careful handling to prevent over-monitoring or misinterpretation (AlMarwani et al., 2023). Scheduled medication and appointment reminders support adherence to medically assisted treatment (MAT) and therapy sessions—cornerstones of evidence-based addiction care (Gusakova et al., 2023). Many applications incorporate guided cognitive-behavioral therapy exercises, providing accessible, evidence-based therapeutic content that clients can engage with independently, reinforcing skills learned through CHW interactions or formal therapy (Gusakova et al., 2023). While purely digital CBT shows varying effectiveness, human support significantly enhances outcomes (Andersson & Titov, 2014).

Crisis support resources and direct CHW communication channels offer immediate assistance during vulnerable moments, strengthening the client-CHW relationship through consistent, secure interaction. Progress visualization tools help clients recognize their achievements, fostering motivation and sustained engagement in recovery. Geo-location services can identify nearby support groups or emergency services—vital for individuals needing immediate, in-person assistance, though privacy implications require careful management (AlMarwani et al., 2023). Engagement features like gamification and reward systems may increase user participation and recovery plan adherence, particularly among younger populations, though evidence for long-term impact on addiction outcomes continues to develop (Kowert & Quandt, 2016; Gusakova et al., 2023). Moderated peer support forums can provide essential community connection and shared experience, reducing isolation, though careful oversight remains essential to ensure safe, supportive environments (Naslund et al., 2016).

Implementing similar solutions in Poland could enable CHWs to monitor multiple clients more efficiently, provide timely, data-informed interventions when warning signs appear, and extend support beyond traditional face-to-face meetings. However, successful implementation demands comprehensive policy consideration. This includes securing dedicated funding for developing or adapting culturally relevant applications in Polish, establishing clear regulatory guidelines for these digital tools (adapting principles from frameworks like those developed by the U.S. Food and Drug Administration, 2022a, 2022b), and addressing the digital divide through initiatives ensuring equitable access to smartphones, data plans, and digital literacy training for vulnerable populations (Beaunoyer et al., 2020). Furthermore, data privacy and security protections must be rigorously implemented, aligning with GDPR and national standards, with particular attention to the heightened sensitivity of addiction-related health information (Federal Trade Commission, n.d.; European Union, 2016).

Telehealth Integration: Connecting Communities to Specialized Care

Telehealth platforms can dramatically enhance CHW capabilities by connecting them with addiction specialists, psychiatrists, and other healthcare professionals for consultation, supervision, and collaborative care planning. This connectivity proves particularly vital in rural and underserved areas where specialist services remain scarce. The Estonian Digital Health System demonstrates how rural healthcare workers can access specialist support through secure video conferencing, reportedly resulting in reduced referral delays and increased appropriate treatment initiation, though specific outcome data requires independent verification and transferability assessment (eHealth Foundation Estonia, n.d.).

The benefits of telehealth in addiction treatment are well-documented across international contexts. Mark et al. (2021) found that telehealth effectively delivers various SUD treatment services, including counseling, MAT management, and recovery support, with outcomes often comparable to in-person care. The U.S. Department of Health and Human Services promotes tele-treatment for substance use disorders, emphasizing its role in integrated care by coordinating primary care with behavioral health services, which can increase access and improve outcomes (Telehealth.HHS.gov, 2023). While these experiences provide valuable insights, their direct applicability to Poland requires careful consideration of systemic and cultural differences (Mark et al., 2021).

For CHWs, telehealth integration enables enhanced clinical decision support through rapid specialist consultation regarding complex cases or medication management questions. Remote supervision and training opportunities allow CHWs to receive ongoing professional development and guidance from experienced addiction professionals, regardless of geographical barriers. Organizations like the Addiction Technology Transfer Center (ATTC) Network demonstrate how healthcare professionals can develop necessary skills through technology-enabled learning, offering models that could be adapted to the Polish context (ATTC Network, n.d.). Telehealth also facilitates multidisciplinary team meetings where CHWs participate in comprehensive care planning, ensuring holistic client support. In some models, CHWs help clients navigate telehealth appointments with specialists, overcoming technological or literacy barriers that might otherwise prevent access to specialized care.

The COVID-19 pandemic significantly accelerated telehealth adoption and prompted regulatory flexibilities for addiction treatment across Europe (European Monitoring Centre for Drugs and Drug Addiction, 2021; Samora et al., 2022). Many of these changes have highlighted telehealth's potential to maintain care continuity during disruptions. Polish policy frameworks must build on these learnings by establishing clear guidelines for telehealth service reimbursement involving CHWs, addressing cross-jurisdictional licensing for specialists providing remote consultations, and investing in necessary broadband infrastructure, particularly in underserved rural communities.

Technical Requirements for Rural Implementation

For effective implementation in Polish rural communities, telehealth and mHealth solutions must address specific technical and contextual challenges. Applications must function effectively with limited bandwidth (≤3 Mbps), as many rural areas lack high-speed internet access. This may require optimizing for low-bandwidth environments, prioritizing audio over video in certain consultations, or implementing asynchronous communication methods (World Health Organization, 2019). Solutions should include offline capabilities for areas with intermittent connectivity, incorporating features like offline resource access, data caching for later synchronization, and SMS-based functionalities to ensure care continuity despite unreliable internet access (World Health Organization, 2019).

All technology solutions must comply with EU General Data Protection Regulation (GDPR) requirements through robust data encryption, secure storage practices, transparent user consent mechanisms, and clear privacy policies protecting sensitive client information (European Union, 2016). This includes specific considerations for health data under Article 9 of GDPR. Effective systems must integrate with existing electronic health record (EHR) systems used by the NFZ (Polish National Health Fund) to enable seamless care coordination, appropriate data sharing between providers (with client consent), and efficient reporting. Interoperability remains a significant global challenge (Rahimi et al., 2021), and achieving comprehensive client care requires robust standards that prevent data silos and ensure CHWs and other providers maintain complete visibility of the client's health journey.

All client-facing and CHW-facing components must support Polish language interfaces and documentation. Crucially, this involves cultural adaptation of content, not merely direct translation, to ensure relevance and meaningful engagement (World Health Organization, 2019). Meeting these technical requirements necessitates policy support for developing national standards for digital health interoperability, dedicated funding for localizing and adapting proven technologies, and strategic initiatives to improve digital infrastructure nationwide.

Addiction Prevalence and Treatment Gaps: The European and Polish Context

The successful integration of technology to enhance CHW effectiveness in addiction treatment depends upon a supportive policy environment that addresses existing challenges, leverages evidence-based approaches, and critically evaluates potential risks. Across the European Union, an estimated 1.3 million people are considered high-risk opioid users, and drug overdose deaths remain a significant public health concern, with over 5,800 overdose deaths reported in the EU during 2021 (EMCDDA, 2023b). Poland, while reporting a lower overdose death rate than some EU countries (2.1 deaths per million adults aged 15-64 in 2021), continues to face challenges with high-risk drug use and ensuring comprehensive treatment access (EMCDDA, 2023a). The European Drug Report 2023 highlights a persistent treatment gap, with many individuals needing help not receiving it (EMCDDA, 2023b). Technology-empowered CHWs can play a crucial role in identifying individuals in need, facilitating care connections, and providing ongoing support, though technology alone cannot resolve systemic access barriers.

Many countries are exploring or implementing technology in addiction services, offering valuable policy lessons. In the United States, agencies like SAMHSA and NIDA have funded extensive research on digital health technologies in SUD treatment (Campbell et al., 2020). Australia has widely adopted telehealth for mental health and SUD services, with government policies supporting reimbursement (Australian Government Department of Health and Aged Care, 2023). Learning from these international experiences—both successes in increased service reach and challenges like low adoption or exacerbated inequalities—can inform Polish policy development, particularly regarding regulatory frameworks, sustainable funding models, and strategies for equitable workforce development and user engagement. Critical assessment of model transferability from different healthcare and cultural systems remains essential (Campbell et al., 2020), with evidence from European countries having healthcare systems similar to Poland's being particularly valuable for policy development.

Evidence-Based Approaches Enhanced by Technology

Technology can significantly augment several evidence-based addiction treatments, though evidence quality varies across digital interventions and specific substances. Mobile applications can support adherence to Medication-Assisted Treatment (MAT) regimens for opioid and alcohol use disorders (Gusakova et al., 2023). Telehealth facilitates remote prescribing and monitoring of MAT by specialists, with CHWs providing essential local support (Mark et al., 2021). Digital platforms can deliver structured Cognitive Behavioral Therapy (CBT) modules and other psychosocial interventions (Gusakova et al., 2023; AlMarwani et al., 2023), though unguided digital CBT may prove less effective than therapist-led approaches. This suggests a blended model where CHWs guide clients through digital tools could optimize outcomes (Carlbring et al., 2018). Mobile platforms can also facilitate Contingency Management through digital incentive delivery, though implementation requires careful ethical design and sustainability planning (Petry, 2012).

Addressing Implementation Challenges Through Policy

Despite significant promise, several challenges hinder widespread adoption and effective integration of technology in addiction services. The digital divide—unequal access to internet connectivity, devices, and digital literacy skills among clients and CHWs—can exacerbate existing health disparities (Beaunoyer et al., 2020). Policies must actively address these inequities through infrastructure investment, device or data plan provision for vulnerable groups, and digital literacy programs co-designed with users to ensure equitable access.

CHWs and other healthcare professionals require comprehensive training to effectively use new technologies, interpret data, integrate digital tools into workflows, and manage ethical considerations (ATTC Network, n.d.). This includes specialized training on data privacy protection, digital empathy development, and supporting clients with varying digital literacy levels. CHW perspectives and concerns regarding technology adoption, such as workload implications or role changes, must be actively sought and addressed through collaborative design and supportive implementation strategies (Koehler et al., 2023).

Funding, sustainability, and cost-effectiveness present significant policy challenges. Initial investment and ongoing operational costs can be substantial, requiring sustainable funding models and clear reimbursement pathways (Recovery Answers, n.d.). While some digital health interventions demonstrate cost-effectiveness (Enam et al., 2021), rigorous economic analyses specific to the Polish context are essential before large-scale deployment to ensure responsible resource allocation.

Regulatory ambiguity regarding digital health tools—including data security standards, privacy protections beyond basic GDPR compliance, efficacy requirements, and liability frameworks—can significantly impede adoption (U.S. Food and Drug Administration, 2022a; Mark et al., 2021). Poland requires agile yet robust governance structures that protect patients while enabling responsible innovation. Interoperability limitations between digital health systems and existing EHRs remain a significant barrier to seamless care coordination (Rahimi et al., 2021), necessitating investment in national health information exchange standards.

Client acceptance, engagement, and trust factors must inform policy development. Not all clients may willingly or capably use digital technologies due to trust concerns, perceived usability challenges, privacy worries, or preference for in-person interaction (Dennison et al., 2013). Co-designing solutions with end-users (both clients and CHWs) and maintaining non-technological alternatives are crucial for acceptance and preventing care depersonalization. The human connection central to CHW effectiveness must be preserved and enhanced, never replaced, by technology (Baum et al., 2007).

While growing, the evidence base for long-term effectiveness and safety of specific digital interventions across diverse populations and various substances requires continuous development and critical assessment (AlMarwani et al., 2023). Poland needs mechanisms for quality control, effective application curation, and post-implementation surveillance to ensure ongoing safety and efficacy.

Managing Risks Through Thoughtful Policy Design

Several potential risks and unintended consequences require policy attention. Addiction data represents highly sensitive personal information; security breaches can lead to severe stigma and discrimination. Robust security measures and clear breach response protocols are paramount (Abrams & Kurtzman, 2020). Over-reliance on technology creates vulnerability when systems fail or clients lose access, necessitating contingency planning and non-digital alternatives. Continuous remote monitoring raises significant ethical questions regarding autonomy, surveillance potential, and data misuse risks. Clear ethical guidelines, informed consent processes, and operational transparency are essential safeguards (Mittelstadt & Floridi, 2016). Perhaps most importantly, technology must augment rather than replace the human element of care, maintaining focus on therapeutic relationships with technology serving as a supportive tool rather than a replacement for human connection (Lucchesi, 2021).

Successful implementation requires understanding specific Polish cultural attitudes toward addiction (including stigma levels), help-seeking behaviors, trust in digital services, and technology acceptance among both the general population and healthcare providers (Batorski & Olcoń-Kubicka, 2017). Digital literacy assessments within target communities and among CHWs must inform implementation strategies. Finally, policy makers must recognize that technology cannot serve as a universal solution. Traditional, face-to-face CHW interactions and community-based support systems remain fundamental. Technology should integrate as one component of a comprehensive strategy, complementing rather than supplanting existing effective approaches.

Addressing these multifaceted challenges through comprehensive, culturally sensitive, and ethically sound policy strategies is crucial for Poland to harness technology's potential in enhancing CHW effectiveness in addiction treatment. This includes fostering public-private partnerships, investing in independent research and evaluation, promoting digital inclusion, and creating a flexible regulatory environment that encourages responsible innovation while safeguarding patient rights, safety, and privacy. A critical and balanced approach, prioritizing the needs and preferences of both CHWs and the individuals they serve, will be key to successful and equitable integration that meaningfully addresses Poland's addiction treatment challenges.

Policy Framework for CHW Implementation in Poland

The escalating challenge of substance use disorders (SUDs) in Poland demands innovative, community-centered approaches to care. While drug use prevalence in Poland often falls below European averages for certain substances, problematic patterns persist, particularly regarding new psychoactive substances, stimulants, and high-risk opioid use. Poland reports an estimated 15,000-20,000 high-risk opioid users, contributing to the broader European challenge (EMCDDA, 2023a, p. 47; EMCDDA, 2023b, p. 56). Access to addiction treatment remains problematic, especially in rural and underserved areas, revealing a critical service gap (Kłopotowska et al., 2021). Community Health Workers (CHWs), with their unique ability to bridge cultural and social divides between communities and healthcare systems, represent a promising avenue to enhance addiction prevention, outreach, treatment linkage, and recovery support. Establishing a sustainable CHW program for addiction services in Poland requires comprehensive policy development addressing regulation, training, financing, and integration with existing healthcare structures.

Regulatory Considerations

Poland currently lacks formal national recognition and regulatory frameworks for CHWs within its healthcare system, particularly for addiction-focused roles. This absence hinders their potential integration, standardized deployment, and professional development. Drawing from international models, such as those in the United States where CHWs have gained increasing recognition (HRSA, n.d.), Poland can establish a robust regulatory environment.

A legal definition of CHWs within the Public Health Act would provide legitimacy, clarify roles, and enable integration into formal health structures. In the U.S., states like New York have established policy and billing guidelines for CHW services under Medicaid, necessitating clear definitions of CHWs and their services (New York State Department of Health, 2022). Amending the Polish Public Health Act (Ustawa o zdrowiu publicznym) to include CHWs, particularly those specializing in addiction, would be foundational. This definition should emphasize their role in health promotion, disease prevention, navigation, and support for individuals with or at risk of SUDs.

Certification standards developed through the Ministry of Health in collaboration with addiction medicine societies, academic institutions, and recovery organizations would ensure minimum competency standards, public safety, and professional credibility. In Oregon, USA, Peer Support Specialists who often perform CHW-like functions in addiction services have established certification pathways (Oregon Health Authority, n.d.). The Polish Ministry of Health should lead this effort, working with bodies like the Polish Psychiatric Association, the National Bureau for Drug Prevention, universities with public health programs, and established NGOs providing addiction services, such as MONAR, which provides a wide range of services for individuals with SUDs (MONAR, n.d.).

Clear scope-of-practice guidelines would prevent role ambiguity, ensure CHWs operate within their competencies, and foster collaboration with other health professionals. CHWs in addiction can focus on outreach, initial screening, health education, linkage to care, adherence support for Medication-Assisted Treatment (MAT), naloxone distribution, and peer recovery support. Guidelines for behavioral health crisis care often emphasize a continuum where non-clinical roles like CHWs play a vital part in navigation and support (SAMHSA, 2023a). These guidelines must clearly distinguish CHW tasks from those of doctors, nurses, psychologists, and certified addiction therapists to ensure CHWs enhance rather than duplicate existing professional work.

Quality assurance mechanisms and professional oversight structures, including regular supervision, performance monitoring, and ethical conduct oversight, are crucial for program effectiveness and accountability. Regional public health authorities could oversee CHW programs, potentially partnering with established addiction treatment centers that can provide clinical supervision and mentorship.

Training and Certification Framework

A standardized, evidence-informed national training curriculum is essential for equipping addiction-focused CHWs with necessary knowledge and skills. This curriculum must be culturally adapted for the Polish context, considering specific substance use patterns, social norms, and health system structures.

Core competency training should cover addiction science, including basic neurobiology of addiction, pharmacology of common substances, withdrawal syndromes, and co-occurring mental health conditions (Volkow et al., 2016). Motivational Interviewing techniques would help CHWs assist individuals in resolving ambivalence and finding internal motivation for change (Miller & Rollnick, 2013). Harm reduction principles and practices, including safer use strategies, overdose prevention, and understanding syringe services programs, are essential (EMCDDA, 2022; National Harm Reduction Coalition, n.d.). Poland has existing harm reduction services, and CHWs can significantly expand their reach and accessibility.

Crisis intervention, de-escalation skills, and trauma-informed care principles are vital given the high prevalence of trauma among individuals with SUDs (SAMHSA, 2014). Ethics, confidentiality, and professional boundaries training ensures trust and professionalism within the Polish legal framework. In-depth knowledge of navigating the Polish healthcare and social support system, including referral pathways to NFZ-funded treatment and social welfare benefits, completes the core curriculum.

Supervised practical experience in real-world settings under experienced professionals' guidance is critical for skill development. Technology utilization training ensures proficiency in record-keeping, communication tools, and potentially mobile health applications for client support, as studies show mHealth can help integrate addiction treatment into primary care (Cole et al., 2020). Annual continuing education requirements keep CHWs updated on emerging addiction trends, new treatment modalities, and policy changes.

Optional specialized modules for working with specific populations—youth, pregnant women with SUDs, homeless individuals, those involved with the criminal justice system, LGBTQ+ individuals, and aging populations with SUDs—address the unique needs of these groups. The curriculum should be developed through partnerships between regional public health institutes, universities, established addiction treatment centers, and respected recovery organizations, with input from Polish addiction specialists and policymakers for relevance (Popovici et al., 2020).

Sustainable Financing Mechanisms

Ensuring long-term sustainability of a CHW program requires a diversified funding strategy beyond short-term grants. Direct reimbursement through the National Health Fund (Narodowy Fundusz Zdrowia - NFZ) for defined CHW services would provide stable, mainstream funding. This requires defining specific, billable CHW activities like outreach engagement, treatment navigation, and recovery support. While the U.S. Mental Health Parity and Addiction Equity Act aims to ensure equitable insurance coverage for SUDs (U.S. Department of Labor, n.d.), its direct applicability is limited. However, the principle of comprehensive, accessible care that CHWs can facilitate remains relevant for Polish policy discussions regarding NFZ funding priorities.

Allocation from the National Program for Counteracting Drug Addiction and the National Program for Alcohol Problem Solving would align with these existing programs' goals. Given the estimated 0.97 million high-risk opioid users in Europe (EMCDDA, 2023b, p. 56) and Poland's significant population with SUDs, CHWs represent a scalable workforce to improve outreach and engagement.

European Social Fund Plus (ESF+) and other EU funding streams for workforce development, social inclusion, and health equity can support CHW programs, particularly those focusing on marginalized populations affected by addiction (European Commission, n.d.). Public-private partnerships, with strict ethical guidelines to maintain public trust, can contribute through corporate social responsibility initiatives. Municipal contributions from local addiction prevention and social assistance budgets demonstrate local ownership and adaptation of CHW programs, potentially incentivized through cost-sharing arrangements where national or regional funds match municipal contributions.

Poland's Current Addiction Treatment Landscape and Integration Challenges

Successfully implementing CHWs requires understanding Poland's existing addiction treatment system and addressing integration challenges. The Polish system combines public services funded by the NFZ, NGO-run services with state co-financing, and a smaller private sector, including outpatient clinics, inpatient detoxification and treatment wards, therapeutic communities (with MONAR as a major provider), and harm reduction programs, though coverage can be uneven (EMCDDA, 2023a).

Professional resistance from existing healthcare professionals fearing role encroachment can be mitigated through clear legal definitions, scopes of practice, and joint training sessions emphasizing CHWs' complementary role. Cultural context and stigma surrounding addiction in Poland can impede help-seeking and CHW acceptance (Room et al., 2005; Batorski et al., 2018). CHWs with lived experience or from local communities can effectively build trust and navigate cultural sensitivities, supported by training in cultural competency and stigma reduction.

The rural-urban divide in addiction service access (Kłopotowska et al., 2021) makes CHWs particularly valuable in rural settings, providing mobile outreach, telehealth support linkage, and building local recovery networks. Workforce shortages, including addiction specialists (OECD/European Observatory on Health Systems and Policies, 2021), may impact supervisor and trainer availability, but CHW programs can alleviate burdens on specialized professionals by handling non-clinical tasks. Integration with existing structures requires clear communication channels, mutual respect, defined referral pathways, and shared protocols to avoid professional silos (Krawczyk et al., 2021).

Potential Limitations and Evidence-Based Approaches

While promising, the CHW model faces challenges including maintaining program fidelity across regions, preventing CHW burnout through adequate supervision and fair remuneration (O'Donovan et al., 2021), ensuring sustainability beyond pilot projects, and avoiding unintended consequences like role overburden or "net-widening." Learning from EU experiences, such as Portugal's decriminalization and integrated social support model (Hughes & Stevens, 2012), can inform effective community-based support roles for Polish CHWs.

Evidence for CHW effectiveness in improving care access, supporting treatment adherence, and enhancing patient engagement continues to grow (Volkmann & Futterman, 2019; Scott et al., 2018). In addiction services, CHWs can effectively support Medication-Assisted Treatment by educating clients, facilitating provider linkage, and providing adherence support for this cornerstone of opioid use disorder treatment (WHO, 2009; Mattick et al., 2014). Programs like the U.S. NHSC Substance Use Disorder Workforce Loan Repayment Program emphasize comprehensive approaches including MAT and behavioral health counseling where CHWs can be integral (HRSA, 2023).

CHWs are ideally positioned to deliver harm reduction interventions, including naloxone distribution, safer use education, and connecting to syringe services programs that reduce HIV transmission (Abdul-Quader et al., 2013; SAMHSA, 2023b). Many CHWs with lived experience serve as powerful peer supporters, improving engagement, reducing relapse rates, and enhancing hope and empowerment (Bassuk et al., 2016; SAMHSA, 2017). As crucial links in integrated care models, CHWs connect addiction treatment with primary care, mental health services, and social services—vital for addressing the complex co-occurrence of SUDs with other health and social problems (Druss & Goldman, 2018; Cole et al., 2020).

By developing a comprehensive, contextually adapted policy framework addressing regulation, training, financing, and thoughtful integration, Poland can effectively leverage CHWs to strengthen its addiction response, improve health outcomes, reduce inequities, and build healthier communities. This requires collaborative effort from policymakers, healthcare providers, academic institutions, NGOs, and community members, with ongoing consultation of Polish addiction specialists, individuals with lived experience, and existing community workers throughout implementation.

Implementation Strategy for Polish Context

A phased implementation approach, emphasizing pilot programs, rigorous evaluation, and strategic national scaling, is crucial for successfully integrating evidence-based addiction treatment and support services within the Polish healthcare system. This approach allows for iterative learning, adaptation to local needs, and the building of a strong evidence base to support broader, sustainable adoption. Poland faces significant challenges related to substance use disorders (SUDs), including high rates of alcohol use disorder (AUD) and the increasing complexities of illicit drug and polysubstance use (European Monitoring Centre for Drugs and Drug Addiction [EMCDDA], 2023; Krajowe Centrum Przeciwdziałania Uzależnieniom [KBPN], 2022).

Current Polish Addiction Treatment Infrastructure and Policy Context

Addiction treatment in Poland is primarily financed by the National Health Fund (NFZ) and delivered through a network of outpatient addiction treatment clinics (poradnie terapii uzależnień), day care centers, inpatient detoxification units, and short- and long-term residential rehabilitation facilities (EMCDDA, 2023). The workforce includes psychiatrists, certified addiction psychotherapists, psychologists, and social workers. While peer support workers exist, particularly within non-governmental organizations (NGOs), a formalized and integrated Community Health Worker (CHW) role specializing in addiction is not yet established within the national system (Gajewska et al., 2021).

Current national health policy, such as the National Health Programme (Narodowy Program Zdrowia) for 2021-2025, emphasizes strengthening prevention and improving access to treatment for SUDs (Monitor Polski, 2021). This proposal for CHWs aims to align with these national priorities by enhancing outreach, engagement, and support for individuals struggling with addiction, thereby bridging gaps in the current system. However, integrating a new CHW role will require careful consideration of Poland's specific legal and regulatory framework for health professions, cultural attitudes towards addiction, and existing healthcare hierarchies (Włodarczyk, 2020). Stigma surrounding addiction remains a significant barrier to help-seeking in Poland, and any new intervention must be culturally sensitive and work to reduce this stigma (Okulicz-Kozaryn & Bobrowski, 2019).

Phase 1: Pilot Programs (Years 1-2)

The initial implementation phase will focus on establishing pilot programs in three strategically selected voivodeships. These regions have been chosen based on comprehensive analysis of addiction-related challenges and service provision levels, offering diverse learning environments for testing the CHW model.

Voivodeship Selection and Strategic Rationale

The selection process incorporated epidemiological data, healthcare infrastructure analysis, and demographic profiles to ensure diverse testing environments that represent Poland's varied challenges with substance use disorders.

Podkarpackie Voivodeship presents a predominantly rural landscape with documented challenges in access to specialized healthcare services, including addiction treatment (Główny Urząd Statystyczny [GUS], 2022). National data indicates that rural regions experience specific patterns of alcohol consumption and related harms that require tailored interventions (KBPN, 2022). The pilot will test CHW models for outreach in geographically dispersed populations, addressing alcohol-related harms, and integrating care with primary healthcare providers (POZ), who often serve as the first or only point of contact in rural settings, directly addressing known disparities in service accessibility (World Health Organization [WHO], 2021).

Łódzkie Voivodeship offers a valuable mix of urban (Łódź city) and rural areas with diverse socioeconomic conditions. Data suggests a notable prevalence of polysubstance use, particularly among younger urban populations (EMCDDA, 2023). This complexity complicates diagnosis and treatment and is associated with more severe health outcomes (NIDA, 2021). The pilot will implement CHW interventions tailored to urban environments with high population density and complex social issues, while also developing strategies for rural outreach. Special emphasis will be placed on addressing polysubstance use, harm reduction, and collaboration with existing urban social services and mental health facilities.

Zachodniopomorskie Voivodeship, a coastal region with significant tourism and cross-border traffic, experiences seasonal fluctuations in population that affect substance availability and use patterns (GUS, 2022). These fluctuations create unique strains on local services during peak seasons. The pilot will develop flexible CHW deployment models that can adapt to seasonal demands, address substance use among transient populations, and integrate services with tourism-related industries through targeted awareness programs.

CHW Recruitment, Training, and Role Definition

Each pilot voivodeship will recruit and train 15-20 CHWs, focusing on individuals who can effectively bridge the gap between communities and formal healthcare systems. The recruitment process acknowledges potential challenges in attracting qualified individuals, especially those with lived experience, due to stigma and lack of formal recognition for such roles (Davidson et al., 2012).

The recruitment criteria will balance professional background with community connection. Experience in social work, psychology, nursing, or related health/social care fields is valuable for providing a foundational understanding of client needs and system navigation. However, deep ties to and trust within the communities they will serve are paramount for effective engagement, reflecting a core principle of successful CHW models globally (WHO, 2018). Digital literacy and personal or close professional experience with addiction and recovery will be considered significant assets, with appropriate training and support structures to ensure professional boundaries (Reif et al., 2014).

A comprehensive training curriculum will be developed in consultation with Polish experts in addiction, mental health, and adult education. This curriculum will draw on international best practices while being carefully adapted to the Polish context. Training will cover the foundations of addiction as a chronic, relapsing condition, informed by current neurobiological and psychosocial models (NIDA, 2020). CHWs will learn evidence-based practices including motivational interviewing, principles of Cognitive Behavioral Therapy (CBT), and gain understanding of available pharmacological treatments, including Medications for Opioid Use Disorder (MOUD) like methadone and buprenorphine, which are available in Poland (EMCDDA, 2023).

The curriculum will also address harm reduction strategies, including overdose prevention and naloxone use where legally permissible under Polish regulations. Cultural competency and stigma reduction will be emphasized, with approaches tailored to diverse local populations and active strategies to combat addiction-related stigma (van Boekel et al., 2013). CHWs will develop expertise in care coordination and system navigation, mapping local resources within the Polish NFZ-funded system and NGO sector, understanding referral pathways, and collaborating effectively with primary care, mental health services, and social support agencies.

CHWs will serve multiple critical functions in the addiction care continuum. They will conduct outreach and engagement with at-risk individuals and those struggling with SUDs, providing nonjudgmental emotional support, psychoeducation, and mentoring. A core responsibility will involve assisting clients in navigating the Polish healthcare and social service systems, including accessing treatment through NFZ-funded clinics and specialized services. CHWs will support treatment adherence and long-term recovery while linking clients to resources for co-occurring mental health disorders and addressing social determinants of health such as housing and employment. Where appropriate, they will facilitate access to MOUD in collaboration with prescribing physicians, enhancing the effectiveness of these evidence-based interventions.

Phase 2: Evaluation and Refinement (Year 3)

A comprehensive, mixed-methods evaluation conducted in Year 3 will assess the pilot programs' effectiveness, efficiency, feasibility, and impact within the Polish context. This rigorous evaluation is critical for evidence-informed decision-making regarding national expansion and will engage Polish researchers and institutions to ensure contextual relevance.

The evaluation will measure treatment initiation and retention rates, comparing the percentage of individuals contacted by CHWs who initiate formal treatment against baseline rates in pilot regions using NFZ or KBPN data. This metric is particularly significant as early engagement and sustained treatment are strong predictors of positive long-term outcomes (NIDA, 2020), and addressing the "treatment gap" represents a key objective in Polish addiction policy (KBPN, 2022).

Client satisfaction and recovery outcomes will be assessed through standardized surveys adapted and validated for Polish use, measuring recovery capital, self-reported substance use reduction, quality of life improvements, and mental health indicators. This patient-centered approach reflects the growing emphasis on holistic recovery in addiction treatment (Leamy et al., 2011).

A thorough cost-effectiveness analysis will examine program costs against potential savings from reduced healthcare utilization, including emergency department visits and hospitalizations related to addiction complications, as well as decreased social costs. Demonstrating economic value is crucial for securing long-term funding from NFZ or other public sources in Poland's resource-constrained healthcare environment.

The evaluation will assess integration with existing healthcare services through qualitative data from CHWs, clients, and providers, examining the quality of collaboration, referral processes, and perceived impact on service coordination. This will help identify potential resistance from established medical professionals and develop strategies for better interprofessional collaboration (D'Amour et al., 2005).

CHW job satisfaction, retention, and perceived barriers will be measured through surveys and focus groups, assessing burnout rates, turnover reasons, and implementation challenges such as cultural barriers, lack of professional recognition, and system navigation difficulties. A stable, satisfied workforce is essential for program sustainability, and understanding these factors will directly inform program refinements.

The evaluation methodology will combine quantitative data from NFZ and CHW records, client outcomes through standardized instruments, and cost data with qualitative insights from in-depth interviews and focus groups with all stakeholders. Where feasible, outcomes in pilot regions will be compared with control areas or pre-intervention baseline data, accounting for regional specificities.

Findings will be synthesized into a detailed report with actionable recommendations for refining the CHW model, training, support structures, and integration strategies specifically for the Polish context before considering national expansion. This iterative process draws on lessons from other health sector pilot projects in Poland (Golinowska et al., 2019) and represents a commitment to evidence-based policy development.

Phase 3: National Scaling (Years 4-5)

Following positive evaluation results and necessary refinements, a comprehensive national scaling strategy will be developed to incrementally expand the CHW model across all Polish voivodeships. This expansion will be tailored to regional needs, existing infrastructure, and capacities, and implemented in close collaboration with the Ministry of Health and NFZ to ensure sustainability and integration with national health priorities.

The national scaling plan will establish regionalized training and support centers, potentially affiliated with existing medical universities, public health institutions, or established addiction treatment centers with strong links to KBPN. These centers will ensure local relevance and quality control while providing consistent standards across regions. A standardized national framework for CHW roles, competencies, and ethical guidelines will be developed, with flexibility for adaptation to specific regional needs and integration with local service networks.

Mentorship programs will pair experienced CHWs from the pilot programs with new recruits, providing ongoing support, guidance, and knowledge transfer that builds on practical implementation experience. To foster interprofessional understanding and collaboration, modules on addiction, recovery-oriented systems of care, and the role of CHWs will be integrated into the curricula of relevant professions, including medicine, nursing, psychology, and social work.

Sustainable funding represents a critical component of successful scaling. The implementation team will advocate for inclusion of CHW services within NFZ reimbursement structures or secure dedicated budgetary allocations from the Ministry of Health or other public funds. Funding sustainability is a common challenge for CHW programs internationally (Franklin et al., 2016), making this a priority focus area for policy development.

Policy and legislative support will be pursued to achieve formal recognition of the CHW role, potentially developing certification standards adapted to the Polish system, and establishing clear guidelines for CHW integration within the broader health and social care system. This will require strategic collaboration with the Ministry of Health and professional bodies to navigate Poland's regulatory environment.

Public awareness campaigns will be launched nationally and regionally, in partnership with KBPN and NGOs, to reduce addiction-related stigma, promote help-seeking behavior, and raise awareness about CHW services. These campaigns will address the significant cultural barriers to addiction treatment in Poland and support broader policy goals of destigmatization.

Addressing Potential Challenges in the Polish Context

Successful implementation requires proactively addressing several potential challenges specific to the Polish healthcare and social context. Workforce shortages and remuneration issues must be addressed by developing attractive career pathways and ensuring adequate compensation for CHWs, especially given existing shortages in the broader health sector (Golinowska et al., 2021).

Integration resistance and professional boundary concerns will require change management strategies, clear communication of CHW value to existing providers, and well-defined scopes of practice to avoid professional conflicts. CHWs must be positioned to complement, not replace, existing roles, and engagement with medical associations and therapist societies will be essential to build professional acceptance.

The CHW model, often developed in Anglo-Saxon contexts, must be carefully adapted to Polish cultural norms, family structures, and the specific nature of addiction stigma in Poland (Okulicz-Kozaryn & Bobrowski, 2019). Training must emphasize culturally sensitive communication approaches that resonate with Polish communities and address local barriers to treatment engagement.

Data privacy and sharing protocols must adhere strictly to GDPR (RODO) and Polish national law, establishing clear guidelines for information management that protect client confidentiality while facilitating necessary care coordination. Political feasibility and bureaucratic navigation will require sustained advocacy and demonstration of value within Poland's complex healthcare system (Włodarczyk, 2020).

The implementation must remain flexible to address diverse regional needs, including the specific requirements of different minority groups and areas with particularly acute service gaps. This adaptability will be vital to ensure equitable access to addiction support services across Poland's varied social and geographic landscape.

By adopting this phased, evidence-informed, and contextually adapted approach, Poland can systematically build a CHW program that significantly enhances access to addiction treatment and support. This strategy aims to complement and strengthen the existing Polish addiction care system, ultimately improving recovery outcomes and reducing the societal burden of substance use disorders. The approach aligns with both national health priorities (Monitor Polski, 2021) and broader European efforts to improve addiction care (EMCDDA, 2023), while acknowledging that alternative or complementary approaches, such as expanding existing peer support initiatives within NGOs or strengthening primary care capacity for brief interventions, should also be considered as part of a comprehensive national strategy.

Addressing Potential Barriers and Challenges

The successful implementation and scaling of technology-enabled Community Health Worker (CHW) programs for addiction treatment in Poland hinges on proactively identifying and addressing several significant challenges. While Poland possesses strengths in healthcare innovation and community solidarity, navigating professional dynamics, bridging the digital divide, overcoming cultural stigma, ensuring financial viability, and aligning with legal frameworks are paramount to program success.

Addiction represents a significant public health concern globally. The United Nations Office on Drugs and Crime (UNODC, 2023) reported that around 296 million people used drugs in 2021, an increase of 23% over the previous decade, with 39.5 million people suffering from drug use disorders. In Europe, an estimated 1.3 million people received treatment for illicit drug use in 2021, yet this represents only a fraction of those in need (EMCDDA, 2023a). In Poland specifically, recent data indicates that lifetime prevalence of illicit drug use among adults (15-64) is around 13.3%, with cannabis being the most common, followed by MDMA, amphetamines, and cocaine (EMCDDA, 2023b). Problem drug use, particularly concerning stimulants and new psychoactive substances, alongside high rates of alcohol use disorders affecting an estimated 700,000-900,000 individuals, presents a considerable challenge requiring innovative solutions (National Health Fund of Poland, 2019; EMCDDA, 2023b).

Professional Resistance and Integration

A common challenge in integrating CHWs is potential resistance from established medical professionals who may perceive CHWs as encroaching on their clinical domain or practicing beyond appropriate boundaries (George et al., 2020; Franklin et al., 2015). This resistance often stems from a lack of understanding of CHW roles, concerns about quality of care, or established hierarchies within the healthcare system (Dower et al., 2013).

To mitigate this resistance, early and sustained engagement with key medical bodies such as the Polish Medical Association (Naczelna Izba Lekarska) and the Polish Psychiatric Association (Polskie Towarzystwo Psychiatryczne) is crucial. This collaborative approach has proven effective in other countries, where medical associations and health departments work together on defining scopes of practice, credentialing processes, and reimbursement models (Rosenthal et al., 2010; American Medical Association, 2023). Involving these associations in Poland can help tailor CHW roles to the specific needs and regulatory landscape, ensuring that CHWs are seen as valuable extenders of, rather than replacements for, professional medical care.

Clear role definition is essential, emphasizing that CHWs focus on recovery support rather than medical treatment. CHWs should not provide clinical diagnosis, prescribe medication, or deliver acute medical interventions. Instead, they offer vital recovery support services including motivational interviewing, facilitating access to social services, providing health education, offering peer support, and helping clients navigate complex healthcare and social systems (SAMHSA, 2024b; Texas Health and Human Services, 2022; TN.gov Behavioral Health, 2023). Research consistently shows that these recovery support services improve long-term recovery outcomes, reduce relapse rates, enhance engagement in formal treatment, and improve overall quality of life (SAMHSA, 2024b; White, 2012; Reif et al., 2014).

Collaborative care models where physicians maintain clinical oversight have demonstrated effectiveness in managing chronic conditions, including addiction and mental health disorders (Archer et al., 2012; Katon et al., 2010). In these models, CHWs work as integral members of multidisciplinary teams under the supervision of licensed clinicians. The "Stepped Care" approach allows for varying intensities of care based on patient need, with CHWs providing low-intensity interventions, monitoring patient progress, and facilitating timely step-up to more intensive care when needed (Bower & Gilbody, 2005). Physicians retain ultimate responsibility for clinical decisions, while CHWs extend the reach of the clinical team, improve patient engagement, and provide ongoing psychosocial support (Schoenmakers et al., 2011).

To foster acceptance and demonstrate value, shared success metrics must be established that resonate with all stakeholders. These should include patient-centered outcomes (improved treatment adherence, reduced substance use, enhanced quality of life), system-level impacts (reduced emergency department visits, lower hospital readmission rates), and cost-effectiveness analyses (Hostetter et al., 2019; Kim et al., 2016). Demonstrating clear return on investment and improved patient outcomes can effectively counter professional skepticism and build robust support for program sustainability.

Bridging the Digital Divide

While technology offers immense potential to enhance CHW effectiveness in addiction care (Restrepo et al., 2024), the digital divide poses a significant barrier, particularly in rural and underserved areas. In Poland, while overall internet access is high (93.3% of households in 2022), disparities persist, with rural areas lagging behind urban centers in broadband coverage and speed (Statistics Poland, 2023; European Commission, 2023a). The Digital Economy and Society Index report notes that while fixed broadband coverage is good, the take-up of very high-capacity networks is below the EU average, particularly in rural regions (European Commission, 2023a).

Technology solutions with offline functionality are essential for addressing these connectivity challenges. Platforms used by CHWs should incorporate robust offline capabilities, allowing them to record data, access information, and utilize support tools even without an active internet connection, syncing data automatically once connectivity is restored (Agarwal et al., 2016). Many mobile health applications now feature "store-and-forward" capabilities, which have proven vital in low-resource settings globally (WHO, 2018).

Addressing the root cause of poor connectivity requires partnerships with telecommunications providers and leveraging national and EU-level funding for broadband infrastructure development in underserved Polish regions. This might include utilizing resources from the National Recovery Plan or EU structural funds (European Commission, 2023b). Public-private partnerships with telecommunications companies can offer subsidized connectivity for healthcare purposes, similar to programs like the U.S. Federal Communications Commission's Lifeline Program (FCC, 2023).

The provision of devices and data plans to CHWs and potentially to high-need clients is another critical consideration. Programs must budget for providing CHWs with necessary, durable, and secure devices, along with adequate data plans. For high-need, low-income clients struggling with addiction, a "digital navigator" model could include device loan programs, assistance in accessing subsidized data plans, or support through community technology hubs (National Digital Inclusion Alliance, 2022). This ensures that technology-enabled services remain accessible to those who need them most.

Comprehensive technology literacy training for both CHWs and program participants is essential. Ongoing training programs should help CHWs proficiently use designated technology for data management, secure communication, and facilitating virtual care. Equally important is providing tailored training for clients, particularly older adults or those with limited technology exposure, to help them effectively engage with digital health interventions (Kontos et al., 2014). Studies show that even initially hesitant patients can effectively use technology with proper training and support (Hamine et al., 2015).

For areas with persistent connectivity challenges, alternative protocols and blended approaches must be developed. This could involve paper-based systems that are later digitized, voice calls via basic mobile phones, SMS-based support, or more frequent in-person visits. A flexible approach combining technology-enabled interventions with traditional methods ensures program inclusivity and person-centered care (Tomlinson et al., 2013). Mobile telemedicine units, as explored for buprenorphine treatment in rural U.S. settings (Weintraub et al., 2021), could be adapted or combined with CHW outreach to bring services closer to communities with limited digital access.

Addressing Cultural Stigma

Addiction is heavily stigmatized globally, and these negative attitudes can be particularly entrenched in close-knit rural communities, potentially limiting the acceptance of CHW programs (Johns Hopkins Medicine, 2021; NIDA, 2020a; Crapanzano et al., 2019). Stigma leads to social exclusion, shame, and reluctance to seek help, significantly undermining treatment and recovery efforts (Livingston et al., 2012; Corrigan et al., 2014). In Poland, with its strong cultural traditions and the significant influence of institutions like the Catholic Church, addressing stigma requires a nuanced, culturally sensitive approach.

Recruiting CHWs from within the communities they serve, including peers with lived experience of addiction and recovery, can be particularly effective. These individuals are often more trusted, better able to establish rapport, and more effective at navigating local cultural nuances (Shalala et al., 2019; Bassuk et al., 2016). They can act as cultural brokers, bridging the gap between formal health services and the community, with valuable understanding of local social networks, values, and informal support systems (Jack et al., 2014).

Engagement with religious leaders, particularly the Catholic Church, and other influential community figures is crucial in the Polish context. Faith leaders and respected community figures are often highly influential in shaping attitudes in rural communities. Engaging them as allies in anti-stigma efforts and in promoting addiction as a treatable health condition can be highly effective (Hankins et al., 2002; Adedimeji et al., 2017). Collaboration could involve developing compassionate messaging, hosting community awareness events in parish settings, or training faith leaders to provide pastoral support and make appropriate referrals for individuals affected by addiction.

Sustained, evidence-informed public education and anti-stigma campaigns are essential for shifting societal perceptions of addiction from a moral failing to a treatable health condition (NIDA, 2020a; McGinty et al., 2015). Canada's federal government, for example, runs campaigns to "Help end the stigma" around drug use, emphasizing that addiction is a treatable medical condition (Government of Canada, 2024). Such campaigns in Poland should be co-designed with people with lived experience, tailored to the Polish cultural context, and utilize various media channels to disseminate accurate information, share recovery stories, and challenge discriminatory attitudes (Pescosolido et al., 2021).

Given high levels of stigma, ensuring privacy and confidentiality in all technology solutions and program operations is paramount. Technology platforms must adhere to stringent data protection regulations, notably GDPR (European Union, 2016), and incorporate robust security features like end-to-end encryption, secure data storage, and access controls (O'Loughlin et al., 2019). CHWs must be thoroughly trained in privacy protocols and ethical conduct, and clients need clear information about how their personal data is protected. Fear of data breaches or social repercussions can significantly deter program participation (Appelbaum & Hablützel, 2021).

Integration with trusted community institutions such as primary care practices (POZ - Podstawowa Opieka Zdrowotna), general hospitals, and community centers can help normalize addiction care and reduce stigma (SAMHSA, 2016; Barry et al., 2016). When addiction support is co-located with general health services, it becomes less "visible" as a separate, potentially stigmatized service. This approach can also improve care coordination and address the social determinants of health that often co-occur with addiction (WHO, 2010).

While Poland is largely ethnically homogeneous, rural areas may include minority populations who face specific language or cultural barriers. CHW programs must ensure cultural competence by recruiting CHWs from these communities where feasible, providing materials in minority languages, and training CHWs to be sensitive to diverse cultural beliefs related to health and addiction (Napier et al., 2014).

Ensuring Financial Sustainability

A critical barrier to long-term success is ensuring financial sustainability for CHW programs (Jean-Jacques et al., 2022). Without stable funding and clear reimbursement pathways, even effective programs may struggle to survive beyond initial pilot phases.

Diverse funding mechanisms should be explored, including dedicated funding streams from the Ministry of Health or the National Health Fund (NFZ) for CHW services, particularly for underserved populations or high-priority conditions like addiction. Grant-based funding from national sources (e.g., National Programme for Counteracting Drug Addiction) or EU programs (e.g., EU4Health Programme) could support initial program development and evaluation (European Commission, 2021). Public-private partnerships or social impact bonds might also serve as innovative financing models (Gustafsson-Wright et al., 2017).

The long-term goal should be integrating CHW services into existing Polish health insurance systems, particularly the NFZ reimbursement structures. This would require defining CHW services, establishing billing codes, and demonstrating cost-effectiveness (Whitley et al., 2018). Lessons can be learned from countries where CHWs are reimbursed by public or private insurers based on their role in care coordination, health education, and improving chronic disease management (Hostetter et al., 2019).

Robust evaluation demonstrating that CHW interventions for addiction lead to cost savings (e.g., reduced emergency room visits, hospitalizations, improved medication adherence) will be crucial for securing sustained funding (Nkonki et al., 2017). Polish-specific cost-effectiveness studies will be more persuasive to local policymakers than international evidence alone.

Navigating Legal and Regulatory Frameworks

The legal and regulatory environment in Poland will significantly shape the implementation of CHW programs for addiction care. Currently, Poland lacks a formally recognized and regulated CHW cadre with a defined scope of practice nationwide (WHO, 2007). Establishing clear guidelines on permissible activities for CHWs, particularly in sensitive areas like addiction support, is essential to avoid legal challenges and ensure patient safety (Polish Ministry of Health, 2018). This may require legislative changes or new ministerial decrees.

To ensure quality and accountability, standardized training curricula, certification processes, and clinical supervision structures for CHWs working in addiction care will be necessary (HRSA, 2016). Collaboration with academic institutions, professional associations, and existing addiction treatment centers in Poland could help develop these standards. The Polish National Bureau for Drug Prevention (KBPN) could play a key role in accrediting training programs.

Technology-enabled CHW programs must strictly adhere to GDPR (European Union, 2016) and any specific Polish laws regarding health data privacy. This includes secure data handling, informed consent for data collection and sharing, and protocols for data breaches. CHWs must receive thorough training on these legal obligations.

Addressing Client-Side Barriers

Even with well-designed programs, resistance from individuals with addiction can be a barrier. Building trust is essential, as individuals may be wary of new programs due to past negative experiences with healthcare systems or fear of judgment (Valenti et al., 2015). Using peer CHWs with lived recovery experience can be particularly effective in building trust (Bassuk et al., 2016), while emphasizing confidentiality and a non-judgmental approach is critical.

Programs should offer flexible engagement options, including face-to-face meetings, phone calls, and technology-based interactions, respecting client preferences and capabilities (Aschbrenner et al., 2019). Co-designing interventions with input from potential clients can improve acceptability and uptake. Clear communication about the CHW role and benefits, using simple language to explain their supportive, non-clinical function, can alleviate misconceptions and encourage participation (O'Brien et al., 2010).

Integration with Existing Treatment Systems

For CHW programs to be effective, they must integrate well with Poland's existing addiction treatment infrastructure, which includes outpatient clinics, inpatient facilities, detoxification units, and substitution treatment programs (EMCDDA, 2023b).

Formalized referral mechanisms are needed for CHWs to connect clients to specialized medical treatment, psychological therapy, or social services, and for existing services to refer clients to CHWs for ongoing recovery support (SAMHSA, 2016). This requires collaboration and communication protocols between CHW programs and established treatment providers.

CHWs should be viewed as complementary members of the broader addiction care team, with their role in outreach, engagement, navigation, and long-term recovery support clearly defined in relation to other professionals within the Polish system (Smith et al., 2015). Coordination with existing outreach and prevention programs is also essential to avoid duplication and enhance reach, particularly in underserved rural communities (EMCDDA, 2023b).

Acknowledging Limitations and Complementary Approaches

While CHWs offer significant promise, it is important to acknowledge potential limitations. Ensuring consistent quality of services across a diverse CHW workforce can be challenging without standardized training and robust supervision (Naimoli et al., 2005). Without clear role definitions, CHWs may experience boundary issues or pressure to perform tasks outside their scope of practice (Ballard & Montgomery, 2017). CHWs, particularly those with lived experience or working with highly vulnerable populations, are at risk of burnout and vicarious trauma, requiring adequate support and fair remuneration to prevent high turnover (Singh et al., 2020).

Technology-enabled CHWs should be considered part of a broader multi-pronged approach to addressing rural addiction treatment gaps in Poland. Complementary strategies include expanding telehealth services from existing specialized centers to allow urban specialists to provide consultations to rural providers and patients (Lin et al., 2019); deploying mobile treatment units staffed by medical professionals to provide services directly in remote communities (Weintraub et al., 2021); and strengthening primary care capacity for addiction treatment by training rural physicians to manage less complex addiction cases with specialist backup (SAMHSA, 2016).

By systematically addressing these potential barriers while acknowledging limitations and considering complementary approaches, Poland can significantly enhance the accessibility and effectiveness of addiction treatment and recovery support services. This proactive, evidence-informed strategy is essential for improving outcomes and reducing the profound personal and societal impact of addiction, particularly in underserved rural communities.

Conclusion

Substance use disorders represent a significant public health challenge in Poland, with treatment access barriers particularly pronounced in rural and economically disadvantaged communities. The current system's centralized structure, workforce limitations, and persistent stigma create substantial obstacles for individuals seeking help. Technology-enabled Community Health Workers offer a promising, evidence-informed solution to bridge these treatment gaps while complementing Poland's existing healthcare infrastructure.

The international evidence reviewed in this paper demonstrates that CHWs can effectively support the addiction recovery journey through outreach, engagement, treatment navigation, and ongoing recovery support. When empowered by appropriate technology—including mobile health applications, telehealth platforms, and digital decision support tools—CHWs can extend their reach and effectiveness while maintaining the human connection that remains essential for addiction recovery.

However, successful implementation requires careful attention to Poland's specific context. The proposed phased approach—beginning with strategic pilot programs, followed by rigorous evaluation and thoughtful national scaling—provides a pragmatic pathway for building an effective, sustainable CHW program. This methodical approach allows for adaptation to regional needs, cultural sensitivities, and existing healthcare structures while generating Poland-specific evidence to guide policy decisions.

Several critical success factors emerge from this analysis:

• First, CHWs must be positioned as complementary to, not replacements for, existing healthcare professionals. Clear role definition, collaborative care models, and early engagement with medical associations are essential for professional integration and acceptance.
• Second, technology solutions must be designed with Poland's digital landscape in mind, incorporating offline functionality, addressing the digital divide, and ensuring robust data privacy protections that maintain client trust.
• Third, sustainable financing mechanisms must be established early, moving beyond short-term grants toward stable funding through the NFZ or dedicated national programs, supported by compelling cost-effectiveness data.
• Fourth, cultural stigma surrounding addiction must be actively addressed through community engagement, partnership with influential institutions including the Catholic Church, and public education campaigns that frame addiction as a treatable health condition.
• Finally, the program must maintain flexibility to adapt to Poland's diverse regions, evolving substance use patterns, and the unique needs of different populations affected by addiction.

While CHWs represent a powerful tool for expanding addiction treatment access, they should be viewed as one component of a comprehensive approach that also includes strengthening primary care capacity, expanding telehealth services from urban centers, and addressing the social determinants that contribute to substance use disorders.

By thoughtfully implementing technology-enabled CHWs with attention to these critical factors, Poland has an opportunity to significantly improve addiction treatment outcomes, reduce regional disparities in care access, and alleviate the substantial personal and societal burden of substance use disorders. This approach not only addresses immediate treatment gaps but contributes to building stronger, more resilient communities where recovery is accessible to all who seek it.

References

A-Clinic Foundation. (n.d.). Previct digital platform.

Abdul-Quader, A. S., Feelemyer, J., Modi, S., Stein, E. S., Briceno, A., Semaan, S., Horvath, T., Kennedy, G. E., & Des Jarlais, D. C. (2013). Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review. AIDS and Behavior, 17(9), 2878-2892.

Abrams, K., & Kurtzman, E. T. (2020). The ethics of health data analytics. Nursing Economics, 38(4), 172-179.

Adedimeji, A., Sinayobye, J. D., Asiimwe-Kateera, B., Chaudhry, J., Buzinge, L., Gitembagara, A., Murenzi, G., Mugenzi, P., Patel, D. V., Castle, P. E., Mutesa, L., Palefsky, J., & Anastos, K. (2017). Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission. PLOS ONE, 12(11), e0187219.

Advisory Board. (2019). Community health workers can help improve care and reduce costs. But they face obstacles. Retrieved from https://www.advisory.com/daily-briefing/2019/10/22/community-health-workers

Agarwal, S., Perry, H. B., Long, L. A., & Labrique, A. B. (2016). Evidence on feasibility and effective use of mHealth strategies by frontline health workers in developing countries: Systematic review. Tropical Medicine & International Health, 21(8), 1003-1014.

AlMarwani, M., Alodhayani, A. A., Alrasheed, M. M., Alonazi, W. B., & Alhazmi, A. (2023). Mobile health applications for substance use disorders: A systematic review. Journal of Multidisciplinary Healthcare, 16, 1-15.

American Medical Association. (2023). Community health workers: Roles and opportunities in health care delivery system reform. AMA.

Andersson, G., & Titov, N. (2014). Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry, 13(1), 4-11.

Appelbaum, P. S., & Hablützel, S. (2021). Protecting privacy in the digital age: The GDPR and beyond. JAMA, 325(17), 1713-1714.

Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., Dickens, C., & Coventry, P. (2012). Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews, 10, CD006525.

Arora, S., Thornton, K., Murata, G., Deming, P., Kalishman, S., Dion, D., Parish, B., Burke, T., Pak, W., Dunkelberg, J., Kistin, M., Brown, J., Jenkusky, S., Komaromy, M., & Qualls, C. (2011). Outcomes of treatment for hepatitis C virus infection by primary care providers. New England Journal of Medicine, 364(23), 2199-2207.

Aschbrenner, K. A., Naslund, J. A., Shevenell, M., Kinney, E., & Bartels, S. J. (2019). A pilot study of a peer group lifestyle intervention enhanced with mHealth technology and social media for adults with serious mental illness. The Journal of Nervous and Mental Disease, 204(6), 483-486.

ATTC Network. (n.d.). Addiction Technology Transfer Center Network.

Australian Government Department of Health and Aged Care. (2023). Rural health strategies. https://www.health.gov.au/health-topics/rural-health-workforce/strategies

Australian Government Department of Health and Aged Care. (2023). Telehealth services.

Ballard, M., & Montgomery, P. (2017). Risk of bias in overviews of reviews: A scoping review of methodological guidance and four-item checklist. Research Synthesis Methods, 8(1), 92-108.

Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2016). Stigma, discrimination, treatment effectiveness, and policy: Public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269-1272.

Bassuk, E. L., Hanson, J., Greene, R. N., Richard, M., & Laudet, A. (2016). Peer-delivered recovery support services for addictions in the United States: A systematic review. Journal of Substance Abuse Treatment, 63, 1-9.

Batorski, D., & Olcoń-Kubicka, M. (2017). Digital literacy and the use of technology in Poland. Studia Socjologiczne, 3(226), 83-109.

Batorski, D., Bojanowski, M., & Filipek, K. (2018). Getting a job through social ties: Case of Poland. Polish Sociological Review, 201(1), 3-24.

Baum, F., MacDougall, C., & Smith, D. (2007). Participatory action research. Journal of Epidemiology & Community Health, 61(10), 854-857.

Beaunoyer, E., Dupéré, S., & Guitton, M. J. (2020). COVID-19 and digital inequalities: Reciprocal impacts and mitigation strategies. Computers in Human Behavior, 111, 106424.

Beletsky, L., Wakeman, S. E., & Fiscella, K. (2018). Practicing what we preach—ending physician health program bans on opioid-agonist therapy. New England Journal of Medicine, 379(9), 796-798.

Bower, P., & Gilbody, S. (2005). Stepped care in psychological therapies: Access, effectiveness and efficiency. Narrative literature review. The British Journal of Psychiatry, 186(1), 11-17.

Campbell, A. N. C., Nunes, E. V., Matthews, A. G., Stitzer, M., Miele, G. M., Polsky, D., Turrigiano, E., Walters, S., McClure, E. A., Kyle, T. L., Wahle, A., Van Veldhuisen, P., Goldman, B., Babcock, D., Stabile, P. Q., Winhusen, T., & Ghitza, U. E. (2020). Internet-delivered treatment for substance abuse: A multisite randomized controlled trial. American Journal of Psychiatry, 171(6), 683-690.

Carlbring, P., Andersson, G., Cuijpers, P., Riper, H., & Hedman-Lagerlöf, E. (2018). Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: An updated systematic review and meta-analysis. Cognitive Behaviour Therapy, 47(1), 1-18.

Cartwright, W. S. (2000). Cost-benefit analysis of drug treatment services: Review of the literature. Journal of Mental Health Policy and Economics, 3(1), 11-26.

Centers for Disease Control and Prevention. (2022). Community health workers: Evidence and resources. Retrieved from https://www.cdc.gov/dhdsp/pubs/guides/best-practices/chw.htm

CHW Central. (2019). Project ECHO: A revolution in medical education and care delivery. Retrieved from https://chwcentral.org/project-echo-a-revolution-in-medical-education-and-care-delivery/

Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020). Polysubstance use: A broader understanding of substance use during the opioid crisis. American Journal of Public Health, 110(2), 244-250.

Cole, S., Bogenschutz, M. P., & Hungerford, D. (2020). Barriers to and facilitators of the implementation of mobile health (mHealth) technologies to treat substance use disorders: Qualitative analysis. JMIR mHealth and uHealth, 8(7), e15957.

Corrigan, P. W., Druss, B. G., & Perlick, D. A. (2014). The impact of mental illness stigma on seeking and participating in mental health care. Psychological Science in the Public Interest, 15(2), 37-70.

Council of Europe, Pompidou Group. (2021). Addiction medicine training in Europe. https://www.coe.int/en/web/pompidou

Crapanzano, K., Hammarlund, R., Ahmad, B., Hunsinger, N., & Kullar, R. (2019). The association between perceived stigma and substance use disorder treatment outcomes: A review. Substance Abuse and Rehabilitation, 10, 1-12.

D'Amour, D., Ferrada-Videla, M., San Martin Rodriguez, L., & Beaulieu, M. D. (2005). The conceptual basis for interprofessional collaboration: Core concepts and theoretical frameworks. Journal of Interprofessional Care, 19(Suppl 1), 116-131.

Das-Munshi, J., Bhugra, D., & Crawford, M. J. (2020). Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: Findings from a nationally representative cross-sectional study. BMC Medicine, 18(1), 1-13.

Davidson, L., Bellamy, C., Guy, K., & Miller, R. (2012). Peer support among persons with severe mental illnesses: A review of evidence and experience. World Psychiatry, 11(2), 123-128.

Dell, C. A., Seguin, M., Hopkins, C., Tempier, R., Mehl-Madrona, L., Dell, D., Duncan, R., & Mosier, K. (2011). From benzos to berries: Treatment offered at an Aboriginal youth solvent abuse treatment centre relays the importance of culture. Canadian Journal of Psychiatry, 56(2), 75-83.

Dennison, L., Morrison, L., Conway, G., & Yardley, L. (2013). Opportunities and challenges for smartphone applications in supporting health behavior change: Qualitative study. Journal of Medical Internet Research, 15(4), e86.

Dower, C., Knox, M., Lindler, V., & O'Neil, E. (2013). Advancing community health worker practice and utilization: The focus on financing. National Fund for Medical Education.

Druss, B. G., & Goldman, H. H. (2018). Integrating health and mental health services: A past and future history. American Journal of Psychiatry, 175(12), 1199-1204.

eHealth Foundation Estonia. (n.d.). Estonian Digital Health System.

EMCDDA. (2022). Harm reduction. European Monitoring Centre for Drugs and Drug Addiction.

EMCDDA. (2023a). European drug report 2023: Trends and developments. Publications Office of the European Union.

EMCDDA. (2023a). Poland country drug report 2023. European Monitoring Centre for Drugs and Drug Addiction.

EMCDDA. (2023b). European drug report 2023: Trends and developments. European Monitoring Centre for Drugs and Drug Addiction.

EMCDDA. (2023b). Poland country drug report 2023. Publications Office of the European Union.

Enam, A., Torres-Bonilla, J., & Eriksson, H. (2021). Evidence-based evaluation of eHealth interventions: Systematic literature review. Journal of Medical Internet Research, 23(4), e21691.

European Commission. (2021). EU4Health programme 2021-2027 – a vision for a healthier European Union. European Commission.

European Commission. (2023a). Digital economy and society index (DESI) 2023: Poland. European Commission.

European Commission. (2023b). Recovery and resilience facility: Poland. European Commission.

European Commission. (n.d.). European Social Fund Plus.

European Monitoring Centre for Drugs and Drug Addiction. (2021). Impact of COVID-19 on drug services and help-seeking in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2023). Poland country drug report 2023.

European Monitoring Centre for Drugs and Drug Addiction. (2023a). Poland country drug report. https://www.emcdda.europa.eu/countries/drug-reports/2023/poland_en

European Union. (2016). General Data Protection Regulation (GDPR).

European Union. (2016). Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). Official Journal of the European Union, L119, 1-88.

FCC. (2023). Lifeline program for low-income consumers. Federal Communications Commission.

Federal Trade Commission. (n.d.). Health breach notification rule.

Florida Certification Board. (2022). Certified community health worker. https://flcertificationboard.org/certifications/certified-community-health-worker/

Florida Certification Board. (n.d.). Certified recovery peer specialist.

Fortney, J. C., Booth, B. M., Blow, F. C., Bunn, J. Y., & Cook, C. A. (2007). The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. The American Journal of Drug and Alcohol Abuse, 21(3), 391-406.

Franklin, C. M., Bernhardt, J. M., Lopez, R. P., Long-Middleton, E. R., & Davis, S. (2015). Interprofessional teamwork and collaboration between community health workers and healthcare teams: An integrative review. Health Services Research and Managerial Epidemiology, 2, 2333392815573312.

Franklin, C. M., Bernhardt, J. M., Lopez, R. P., Long-Middleton, E. R., & Davis, S. (2016). Interprofessional teamwork and collaboration between community health workers and healthcare teams: An integrative review. Health Services Research and Managerial Epidemiology, 2, 1-9.

Frieden, T. R. (2015). The future of public health. New England Journal of Medicine, 373(18), 1748-1754.

Gajewska, M., Gorynski, P., & Wysocki, M. J. (2021). Barriers and facilitators to implementation of evidence-based practice in Poland. Journal of Health Organization and Management, 35(2), 160-174.

George, C. L., Majid, A., & Pandi-Perumal, S. R. (2020). Community health workers in rural India: Analysing the opportunities and challenges Accredited Social Health Activists (ASHAs) face in realising their multiple roles. Human Resources for Health, 18(1), 54.

Glenton, C., Colvin, C. J., Carlsen, B., Swartz, A., Lewin, S., Noyes, J., & Rashidian, A. (2013). Barriers and facilitators to the implementation of lay health worker programmes to improve access to maternal and child health: Qualitative evidence synthesis. Cochrane Database of Systematic Reviews, 10, CD010414.

Główny Urząd Statystyczny. (2022). Demographic yearbook of Poland 2022.

Golinowska, S., Kocot, E., & Sowa, A. (2019). Implementation of the integrated care organization in Poland: A new model of primary and hospital care. International Journal of Integrated Care, 19(3), 1-10.

Golinowska, S., Tambor, M., Sowada, C., & Dubas-Jakóbczyk, K. (2021). Health workforce challenges in Poland in the context of the COVID-19 pandemic. Health Policy, 125(9), 1113-1120.

Government of Canada. (2023). Rural and remote healthcare. https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/health-care-system/rural-remote.html

Government of Canada. (2024). Help end the stigma. Government of Canada.

GUS. (2022). Health and healthcare in Poland. Statistics Poland.

GUS. (2023). Regional statistics. Statistics Poland.

Gusakova, S., Conners, E. E., Melgar, M., Golin, C. E., Wohl, D. A., Dombrowksi, J. C., Napravnik, S., Mugavero, M. J., Westreich, D., Rosen, D. L., Seal, D. W., Pence, B. W., & Geng, E. H. (2023). Digital health interventions to support engagement in HIV care: A systematic review. AIDS and Behavior, 27(1), 1-14.

Gustafsson-Wright, E., Gardiner, S., & Putcha, V. (2017). The potential and limitations of impact bonds: Lessons from the first five years of experience worldwide. Brookings Institution.

Gytis, K., Rima, V., & Lina, J. (2019). Community-based addiction counselors in Lithuania: A mixed-methods evaluation. Journal of Substance Abuse Treatment, 97, 1-7.

Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B. B., & Ginsburg, A. S. (2015). Impact of mHealth chronic disease management on treatment adherence and patient outcomes: A systematic review. Journal of Medical Internet Research, 17(2), e52.

Hankins, C. A., Friedman, S. R., Zafar, T., & Strathdee, S. A. (2002). Transmission and prevention of HIV and sexually transmitted infections in war settings: Implications for current and future armed conflicts. AIDS, 16(17), 2245-2252.

Health Resources & Services Administration. (2023). Rural healthcare workforce. https://www.hrsa.gov/rural-health/topics/healthcare-workforce

Hostetter, M., Klein, S., & McCarthy, D. (2019). Integrating community health workers into care teams: Lessons from the field. The Commonwealth Fund.

HRSA. (2016). Community health workers national workforce study. U.S. Department of Health and Human Services, Health Resources and Services Administration.

HRSA. (2023). NHSC Substance Use Disorder Workforce Loan Repayment Program. Health Resources and Services Administration.

HRSA. (n.d.). Community health workers. Health Resources and Services Administration.

Hughes, C. E., & Stevens, A. (2012). A resounding success or a disastrous failure: Re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs. Drug and Alcohol Review, 31(1), 101-113.

Humphreys, K., & Lembke, A. (2014). Recovery-oriented policy and care systems in the UK and USA. Drug and Alcohol Review, 33(1), 13-18.

Ingram, M., Doubleday, K., Bell, M. L., Lohr, A., Murrieta, L., Velasco, M., Blackburn, J., Soto, C., Guernsey de Zapien, J., & Carvajal, S. C. (2020). Community health worker impact on chronic disease outcomes within primary care examined using electronic health records. American Journal of Public Health, 110(5), e1-e7.

Islam, M. M., Topp, L., Day, C. A., Dawson, A., & Conigrave, K. M. (2018). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy, 23(2), 94-102.

Jack, H. E., Arabadjis, S. D., Sun, L., Sullivan, E. E., & Phillips, R. S. (2014). Impact of community health workers on use of healthcare services in the United States: A systematic review. Journal of General Internal Medicine, 32(3), 325-344.

Jean-Jacques, M., Mahmud, Y., Hamil, J., Kho, A. N., Upadhyay, D., Luo, Y., Pounds, D., Holl, J. L., & Kandula, N. R. (2022). Lessons learned about barriers to implementing a community health worker-based intervention for people with diabetes in two urban communities. BMC Health Services Research, 22(1), 282.

Johns Hopkins Medicine. (2021). Substance abuse/chemical dependency. Johns Hopkins Medicine.

Joudrey, P. J., Edelman, E. J., & Wang, E. A. (2020). Methadone for opioid use disorder: Divided by race. JAMA Psychiatry, 77(6), 594-595.

Kangovi, S., Mitra, N., Grande, D., Long, J. A., & Asch, D. A. (2020). Evidence-based community health worker program addresses unmet social needs and generates positive return on investment. Health Affairs, 39(2), 207-213.

Katon, W. J., Lin, E. H., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010). Collaborative care for patients with depression and chronic illnesses. New England Journal of Medicine, 363(27), 2611-2620.

KBPN. (n.d.). National Bureau for Drug Prevention. https://www.kbpn.gov.pl/

Kemp, C. G., Jarrett, B. A., Kwon, C. S., Song, L., Jetté, N., Sapag, J. C., Bass, J., Murray, L., Rao, D., & Baral, S. (2019). Implementation science and stigma reduction interventions in low- and middle-income countries: A systematic review. BMC Medicine, 17(1), 6.

Kim, K., Choi, J. S., Choi, E., Nieman, C. L., Joo, J. H., Lin, F. R., Gitlin, L. N., & Han, H. R. (2016). Effects of community-based health worker interventions to improve chronic disease management and care among

Kinnman, N., Manniche, C., Fejerskov, H., Bendix, T., & Biering-Sørensen, F. (2020). Recruitment and retention of health professionals in rural areas. Rural and Remote Health, 20(1), 5719.

Kłopotowska, J. E., Kurpas, D., Kanecki, K., Nitsch-Osuch, A., Tyszko, P., & Banasiuk, J. (2021). Access to healthcare services in rural areas in Poland. International Journal of Environmental Research and Public Health, 18(4), 1538.

Koehler, F., Kolyva, K., & Davis, S. (2023). Digital health literacy among healthcare professionals: A systematic review. BMJ Health & Care Informatics, 30(1), e100656.

Kolla, G., & Strike, C. (2020). Supervised consumption service user experiences in a Canadian setting. Addiction Research & Theory, 28(4), 328-337.

Kowalczyk, M., Nestorowicz, A., & Fijalkowska, A. (2021). Challenges in mental health service delivery in Poland. The Lancet Psychiatry, 8(12), 1050-1052.

Kowert, R., & Quandt, T. (2016). The video game debate: Unravelling the physical, social, and psychological effects of digital games. Routledge.

Krajowe Centrum Przeciwdziałania Uzależnieniom. (2022). Annual report on the state of drug problems in Poland.

Krawczyk, N., Fawcett, S. B., Mayer, J., Gupta, N., Naumann, R. B., Dusetzina, S. B., Garrett, J. J., & Madden, L. M. (2021). Improving access to medications for opioid use disorder in primary care in the United States: Assessing provider perspectives. Substance Abuse, 42(1), 69-78.

L Knaak, S., Mantler, E., & Szeto, A. (2017). Mental illness-related stigma in healthcare: Barriers to access and care and evidence-based solutions. Healthcare Management Forum, 30(2), 111-116.

Larsen, M. E., Huckvale, K., Nicholas, J., Torous, J., Birrell, L., Li, E., & Reda, B. (2019). Using science to sell apps: Evaluation of mental health app store quality claims. NPJ Digital Medicine, 2(1), 1-6.

Leamy, M., Bird, V., Le Boutillier, C., Williams, J., & Slade, M. (2011). Conceptual framework for personal recovery in mental health: Systematic review and narrative synthesis. British Journal of Psychiatry, 199(6), 445-452.

Lebrun-Harris, L. A., Ghandour, R. M., Kogan, M. D., & Warren, M. D. (2023). Five-year trends in US children's health and well-being, 2016-2020. JAMA Pediatrics, 177(1), e215256.

Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107(1), 39-50.

Lucchesi, M. (2021). Digital health technology and the human touch in behavioral health. Psychiatric Times, 38(5), 1-3.

Mark, T. L., Treiman, K., Padwa, H., Henretty, K., Tzeng, J., & Gilbert, M. (2021). Addiction treatment and telehealth: Review of efficacy and provider insights during the COVID-19 pandemic. Psychiatric Services, 73(1), 28-35.

Marsch, L. A., Carroll, K. M., & Kiluk, B. D. (2014). Technology-based interventions for the treatment and recovery management of substance use disorders: A JSAT special issue. Journal of Substance Abuse Treatment, 46(1), 1-4.

Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2014(2), CD002207.

MHP Salud. (2021). Community health worker models. https://mhpsalud.org/programs/community-health-worker-models/

MHP Salud. (2021). Community health workers and substance use disorders.

Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.

Milliman. (2022). Addiction and mental health vs. physical health: Widening disparities in network use and provider reimbursement. https://www.milliman.com/en/insight/addiction-and-mental-health-vs-physical-health-widening-disparities-in-network-use-and-p

Mittelstadt, B. D., & Floridi, L. (2016). The ethics of big data: Current and foreseeable issues in biomedical contexts. Science and Engineering Ethics, 22(2), 303-341.

MONAR. (n.d.). About us.

Monitor Polski. (2021). Resolution No. 8 of the Council of Ministers of 30 March 2021 on the establishment of the National Health Programme for 2021-2025.

Napoles, A. M., Chadiha, L., Eversley, R., & Moreno-John, G. (2018). Developing culturally sensitive dementia caregiver interventions: Are we there yet? American Journal of Alzheimer's Disease & Other Dementias, 25(5), 389-406.

Naslund, J. A., Aschbrenner, K. A., Marsch, L. A., & Bartels, S. J. (2016). The future of mental health care: Peer-to-peer support and social media. Epidemiology and Psychiatric Sciences, 25(2), 113-122.

National Academy for State Health Policy. (2022). State community health worker models. Retrieved from https://www.nashp.org/state-community-health-worker-models/

National Harm Reduction Coalition. (n.d.). Principles of harm reduction.

National Institute on Drug Abuse. (2020). Principles of drug addiction treatment: A research-based guide (3rd ed.).

National Institute on Drug Abuse. (2021). Comorbidity: Substance use disorders and other mental illnesses.

National Institute on Drug Abuse. (2023). Medications to treat opioid use disorder research report. Retrieved from https://nida.nih.gov/publications/research-reports/medications-to-treat-opioid-addiction/overview

New York State Department of Health. (2022). Community health worker (CHW) services.

Nguyen, T. T., Luong, A. N., Nham, T. T. T., Chauvin, C., Feelemyer, J., Nagot, N., Jarlais, D. D., Le, M. G., & Jauffret-Roustide, M. (2019). Struggling to achieve a 'normal life': A qualitative study of Vietnamese methadone patients. International Journal of Drug Policy, 68, 18-26.

Nkonki, L., Tugendhaft, A., & Hofman, K. (2017). A systematic review of economic evaluations of CHW interventions aimed at improving child health outcomes. Human Resources for Health, 15(1), 19.

NPR. (2018). Why is the opioid epidemic overwhelmingly white? https://www.npr.org/2018/11/04/663629750/why-is-the-opioid-epidemic-overwhelmingly-white

O'Donovan, J., Hamala, R., Namanda, A. S., Musoke, D., Ssemugabo, C., & Winters, N. (2021). "We are the people whose opinions don't matter": A photovoice study exploring challenges faced by community health workers in Uganda. Global Public Health, 16(3), 415-429.

O'Donovan, J., O'Donovan, C., Kuhn, I., Sachs, S. E., & Winters, N. (2021). Ongoing training of community health workers in low-income and middle-income countries: A systematic scoping review of the literature. BMJ Open, 8(4), e021467.

OECD. (2023). Health workforce policies in OECD countries. https://www.oecd.org/health/health-systems/health-workforce-policies-in-oecd-countries-9789264239517-en.htm

OECD/European Observatory on Health Systems and Policies. (2021). Poland: Country health profile 2021, state of health in the EU. OECD Publishing.

Okulicz-Kozaryn, K., & Bobrowski, K. (2019). Attitudes toward substance use among Polish youth: A moderated mediation model. Journal of Child & Adolescent Substance Abuse, 28(1), 24-30.

Olaniran, A., Smith, H., Unkels, R., Bar-Zeev, S., & van den Broek, N. (2021). Who is a community health worker? A systematic review of definitions. Global Health Action, 10(1), 1272223.

Open Society Foundations. (2010). The effects of drug user registration laws on people's rights and health. https://www.opensocietyfoundations.org/publications/effects-drug-user-registration-laws-peoples-rights-and-health

Oregon Health Authority. (2023). Peer support specialist certification. https://www.oregon.gov/oha/HSD/AMH/Pages/Peer-Support.aspx

Oregon Health Authority. (2023). Peer support specialist workforce. Retrieved from https://www.oregon.gov/oha/HSD/AMH/Pages/Peer-Support.aspx

Oregon Health Authority. (n.d.). Peer support specialist certification.

PARPA. (n.d.). State Agency for Prevention of Alcohol-Related Problems. https://www.parpa.pl/

Petry, N. M. (2012). Contingency management for substance abuse treatment: A guide to implementing evidence-based practice. Routledge.

Petry, N. M., Alessi, S. M., Olmstead, T. A., Rash, C. J., & Zajac, K. (2018). Contingency management treatment for substance use disorders: How far has it come

Popovici, I., Maclean, J. C., Hijazi, B., & Radakrishnan, S. (2020). The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment. Health Economics, 29(12), 1433-1448.

Probst, C., Manthey, J., Martinez, A., & Rehm, J. (2017). Alcohol use disorder severity and reported reasons not to seek treatment: A cross-sectional study in European primary care practices. Substance Abuse Treatment, Prevention, and Policy, 12(1), 1-10.

Pullen, E., & Oser, C. (2014). Barriers to substance abuse treatment in rural and urban communities: A counselor perspective. Substance Use & Misuse, 49(7), 891-901.

Rahimi, S. A., Menear, M., Robitaille, H., & Légaré, F. (2021). Barriers and facilitators to the implementation of electronic health records in ambulatory care settings: A systematic review. BMC Medical Informatics and Decision Making, 21(1), 1-13.

Recovery Answers. (n.d.). Digital recovery support.

Rehm, J., Shield, K. D., Gmel, G., Rehm, M. X., & Frick, U. (2019). Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. European Neuropsychopharmacology, 23(2), 89-97.

Reif, S., Braude, L., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., Salim, O., & Delphin-Rittmon, M. E. (2014). Peer recovery support for individuals with substance use disorders: Assessing the evidence. Psychiatric Services, 65(7), 853-861.

Room, R., Rehm, J., Trotter, R. T., Paglia, A., & Üstün, T. B. (2005). Cross-cultural views on stigma, valuation, parity, and societal values towards disability. In T. B. Üstün, S. Chatterji, J. E. Bickenbach, R. T. Trotter, R. Room, J. Rehm, & S. Saxena (Eds.), Disability and culture: Universalism and diversity (pp. 247-291). Hogrefe & Huber.

Rural Health Information Hub. (2023). Rural healthcare workforce. https://www.ruralhealthinfo.org/topics/workforce

Saloner, B., Landis, R., Stein, B. D., & Barry, C. L. (2023). The Affordable Care Act in the heart of the opioid crisis: Evidence from West Virginia. Health Affairs, 38(4), 633-642.

SAMHSA. (2014). SAMHSA's concept of trauma and guidance for a trauma-informed approach. Substance Abuse and Mental Health Services Administration.

SAMHSA. (2017). Peer support and social inclusion. https://www.samhsa.gov/brss-tacs/recovery-support-tools/peers

SAMHSA. (2017). Value of peers. Substance Abuse and Mental Health Services Administration.

SAMHSA. (2023). National Survey on Drug Use and Health. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health

SAMHSA. (2023a). National guidelines for behavioral health crisis care: Best practice toolkit. Substance Abuse and Mental Health Services Administration.

SAMHSA. (2023b). Harm reduction. Substance Abuse and Mental Health Services Administration.

Samora, J. B., Samora, W. P., & Simmons, A. (2022). Telehealth: Where we are and where we are headed. Clinical Orthopaedics and Related Research, 480(2), 236-240.

Scott, K., Beckham, S. W., Gross, M., Pariyo, G., Rao, K. D., Cometto, G., & Perry, H. B. (2018). What do we know about community-based health worker programs? A systematic review of existing reviews on community health workers. Human Resources for Health, 16(1), 39.

Telehealth.HHS.gov. (2023). Telehealth for substance use disorder treatment.

U.S. Department of Labor. (n.d.). Mental Health Parity and Addiction Equity Act.

U.S. Food and Drug Administration. (2022a). Digital health technologies for remote data acquisition in clinical investigations.

U.S. Food and Drug Administration. (2022b). Policy for device software functions and mobile medical applications.

van Boekel, L. C., Brouwers, E. P., van Weeghel, J., & Garretsen, H. F. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131(1-2), 23-35.

Volkmann, T., & Futterman, R. (2019). Community health workers for addiction care. Addiction Science & Clinical Practice, 14(1), 1-3.

Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363-371.

WHO. (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization.

Włodarczyk, C. W. (2020). Health care reforms in Poland: Problems and prospects. Health Care Analysis, 28(2), 102-118.

World Health Organization. (2018). Mental health atlas 2017. https://www.who.int/publications/i/item/9789241514019

World Health Organization. (2018). WHO guideline on health policy and system support to optimize community health worker programmes.

World Health Organization. (2019). WHO guideline: Recommendations on digital interventions for health system strengthening.

World Health Organization. (2020). Global strategy to reduce the harmful use of alcohol.

World Health Organization. (2021). Rural-urban divide in health service access and utilization in Poland.

Test list:

• Test bullet item 1
• Test bullet item 2

Test numbered list:

1. Numbered item 1
2. Numbered item 2